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Histone post-translational modifications (PTMs) are important players in 
chromatin regulation. While the majority of studies on histone modifications is 
centered on those located on the histone tails, here we focused on different 
modifications on the globular domain of histone H3. In this work, we aimed to 
study the poorly understood H3K122succ, characterize the role this modification 
plays in transcription and explore a possible synergistic effect between the 
acetylations of lysine 56, 64 and 122 on H3. 
In the first part of this work, we show that H3K122succ is enriched on active 
promoters and is associated with active gene transcription. We identified 
p300/CBP as the succinyltransferases responsible for its establishment and 
SIRT5 as a novel desuccinylase capable of removing H3K122succ. We 
demonstrate that, in vitro, chromatin enriched by H3K122succ transcribes more 
efficiently than unmodified chromatin, revealing that H3K122succ is not simply 
correlated with active transcription, but can directly stimulate it. Moreover, we 
show that H3K122succ destabilizes the nucleosome structure, leading to 
increased DNA accessibility.  
In the second part of this thesis, we compared the effects of H3K56ac, 
H3K64ac, H3K122ac and combinations of these acetylations in transcription. 
Our results confirm that all three acetylations, previously shown to be 
associated with active regulatory regions, stimulate transcription in vitro. In 
addition, combinations of these modifications lead to higher transcription. 
Furthermore, we identify sharp promoters as a subset of promoters regulated by 




H3K64ac and H3K122ac have an increased effect on genes regulated by sharp 


























Histon-posttranslationale Modifikationen spielen eine wichtige Rolle in der 
Chromatinregulierung. Während sich die Mehrheit der Studien auf N-terminale 
Histonmodifikationen konzentrieren, haben wir uns in dieser Dissertation auf 
verschiedene Modifikationen innerhalb der globulären Domäne von Histon H3 
fokussiert. Das Ziel dieser Arbeit war es die bisher weniger erforschte 
Modifikation H3K122succ zu untersuchen und die Rolle dieser Modifikation bei 
der Transkription zu charakterisieren. Desweiteren untersuchen wir einen 
möglichen synergistischen Effekt auf die Transkription zwischen den H3 
Acetylierungen von Lysin 56, 64 und 122. 
Im ersten Teil dieser Arbeit zeigen wir, dass H3K122succ an aktiven 
Promotoren angereichert ist und mit der aktiven Gentranskription assoziiert ist. 
Wir identifizierten p300/CBP als verantwortliche Succinyltransferasen für 
H3K122succ und SIRT5 als eine neuartige Desuccinylase, die in der Lage ist, 
H3K122succ zu entfernen. Wir zeigen, dass mit H3K122succ angereichertes 
Chromatin in vitro effizienter transkribiert wird als unmodifiziertes Chromatin. 
Dies zeigt, dass H3K22succ nicht nur mit der aktiven Transkription korreliert, 
sondern diese auch direkt stimulieren kann. Darüber hinaus demonstrieren wir, 
dass H3K122succ die Nukleosomenstruktur destabilisiert, was zu einer 
erhöhten Zugänglichkeit der DNA führt. 
Im zweiten Teil dieser Arbeit haben wir die Wirkungen von H3K56ac, H3K64ac, 
H3K122ac und Kombinationen dieser Acetylierungen auf die Transkription 
verglichen. Unsere Ergebnisse bestätigen, dass alle drei Acetylierungen von 
denen zuvor gezeigt wurde, dass sie mit aktiven regulatorischen Regionen 
assoziiert sind, die Transkription in vitro stimulieren. Darüber hinaus führen 




Weiteren identifizieren wir „sharp promoters“ als eine Untergruppe von 
Promotoren, die durch diese Modifikationen reguliert werden. Unsere Daten 
legen nahe, dass die Kombinationen von H3K56ac, H3K64ac und H3K122ac 
einen erhöhten Effekt auf die Transkriptionlevel von Genen haben, die durch 
„sharp promoters“ reguliert werden, verglichen mit den einzelnen 



































The term “epigenetics” was first employed by Conrad H. Waddington in 1942 to 
describe “the branch of biology which studies the causal interactions between 
genes and their products, which bring the phenotype into being”1. Since then, 
several additional definitions have been suggested. Although, the exact 
definition of “epigenetics” is still under discussion, it is commonly accepted  that 
epigenetics refers to the study of heritable changes in gene expression that are 
not the result of changes of the DNA sequence2. Among the best studied 
“epigenetic factors” are covalent modifications of DNA bases, histone variants 
and PTMs of histones amino acids.  
 
3.2 Chromatin organization 
The nuclear DNA in eukaryotic cells follows a well-structured organization, 
which not only allows the long DNA molecules to fit in the small 1-10 m-
diameter nucleus, it also safeguards easy accessibility to any part of the DNA 
sequence. This accessibility is of crucial importance to numerous cell 
processes, such as transcription3, DNA replication4 and DNA repair5.  
The basic unit of chromatin, the nucleosome, consists of 2 copies of each core 
histone (H2A, H2B, H3 and H4), organized in a histone octamer, wrapped by 
147 base pairs (bp) of DNA6. The organization of higher order chromatin 
structures comprises several levels including: the 10 nm chromatin structure - 
also known as “beads on a string” – where the nucleosomes are spaced by 10 to 
80 bp of linker DNA; 300 and 700 nm chromatids and on the highest level the 





Figure 3.1 Chromatin organization 
The nucleosomal DNA is organized into different levels of compaction ranging from the 2 nm-diameter 
naked DNA to the 1400 nm-diameter mitotic chromosome. Adapted from Jansen et al., 2011. 
 
3.3 Histone structure and nucleosome formation 
Histones are among the most evolutionarily conserved proteins in eukaryotes. 
Histones are small, highly positively charged proteins that share a common 
structure composed of two domains: the histone tails and the fold domain9. 
All core histones contain N-terminal tails and, in addition, H2A has a C-terminal 
tail. The histone tails are flexible structures that protrude from the nucleosome 
core structure10. They are known to interact with the nucleosomal DNA, the 
linker DNA and, in case of the H4 tail, with the acidic patch, a negatively 




nucleosomes. The N-terminal tail of H4 is thought to play an important role in 
the formation of higher order chromatin structures whereas the N-terminal tail of 
H2B has been shown to be necessary for chromosome condensation9. The 
removal of the histone tails results in an increased accessibility to the 
nucleosomal DNA. 
The histone fold domains, also known as the histone globular domains, are 
essential for the formation of the nucleosome. Although the fold is not 
conserved at the sequence level between histones, its structure is. The globular 
domain is composed of 3 -helices (1, 2 and 3) connected by 2 short -
loops (L1 and L2). The loops mediate the heterodimerization of H2A-H2B and 
H3-H4 as following: the L1 loop of one histone aligns with the L2 loop of the 
other, in what is referred to as the handshake motif12. Two H3-H4 dimers 
dimerize through a four-helix bundle at the dyad axis, forming (H3-H4)2 
tetramers13 (figure 3.2A).  
 
Figure 3.2 - Nucleosome structure 
A Representation of the dimerization of H2A-H2B dimers and H3-H4 tetramers during octamer formation. B 







In the nucleosome (figure 3.2B), an (H3-H4)2 tetramer is centered at the dyad 
axis, surround on each side by a H2A-H2B heterodimer, which dock at the DNA 
entry and exit sites14,15. The protein complex composed by a (H3-H4)2 tetramer 
and two H2A-H2B heterodimers is known as the histone octamer. 
 
3.4 Histone variants 
One way how chromatin structure and function are regulated is through histone 
variants. For the exception of H4 which only has one, all core histones in 
metazoans have multiple variants16. The variants of the same histone vary not 
only in sequence, but also in genomic location and regulation. Histones can be 
classified into two general groups: canonical and replacement histones. 
The main feature that distinguishes canonical from replacement histones 
regards the fact that the expression of canonical histones is cell cycle 
dependent, in other words they are mainly expressed and incorporated into 
chromatin during S phase, when the DNA undergoes replication. This is 
important as they will be necessary to assemble the newly synthesized 
chromatin. To facilitate the large need of histones during this phase, there are 
several gene copies for each canonical histone in the genome. Canonical 
histone genes lack introns and have a stem loop structure at the 3’ end of their 
mRNAs. The canonical histones are often referred to as simply H2A, H2B, H3 
and H416,17.  
Replacement histones, unlike canonical histones, are expressed throughout the 
cell cycle. They are only biallelic and often contain introns. Replacement 
histones are sometimes poly-adenylated at the 3’ end of their mRNAs and can 




Among the core histones, H2A has the largest number of replacement histones, 
including macroH2A, H2A.B, H2A.Z and H2A.X. Some of them are conserved 
through evolution, like H2A.Z, while others are specific to vertebrates or 
mammals like macroH2A and H2A.B. MacroH2A, the largest of all H2A variants, 
is enriched at the inactive mammalian X-chromosome, and is associated with 
gene silencing. Both H2A.Z and H2A.X are constitutively expressed and found 
throughout the genome1617, with H2A.Z being particularly enriched at intergenic 
regions18. 
H2B has significantly less replacement histones that H2A. The few that have 
been studied seem to have very specialized roles and can be found in specific 
locations18. As an example, TH2B, a testis-specific histone, replaces H2B 
during meiosis and is the main H2B in round and elongating spermatids19.  
Only recently, a variant for H4 was found: H4G. Histone H4G is expressed in 
several human cell lines, but it is overexpressed in particular tumor-stages of 
breast cancer patients. Initial data on this variant suggests H4G induces 
ribosomal DNA (rDNA) transcription in breast cancer tissues20. 
 
3.4.1 H3 variants 
Histone H3 has two canonical forms: H3.1 and H3.2, which differ on a single 
nucleotide located in the globular domain (figure 3.3). H3.1 and H3.2 are usually 
referred to as H3. While H3.2 is present in all metazoans, H3.1 only exists in 
mammals. Besides H3.1 and H3.2, in mammals several H3 replacement 
histones have been identified: H3.3, cenH3 (CENP-A in humans) and H3T (H3t 
in humans). Additionally, there are two primate-specific replacement histones: 




H3.3 has a very high sequence homology with the canonical H3, differing in only 
four nucleotides - one in the N-terminal tail and three in the globular domain – 
comparing to H3.2 (figure 3.3)21. 
 
Figure 3.3 - Sequence alignment of human H3 variants. 
The amino acid sequences of the human H3 variants were aligned and compared to H3.3. The differences 
in sequenced are highlighted as following: H3.1 and H3.2 in purple, H3t in gray, H3.X and H3.Y in yellow 
and CENP-A in blue. The different amino acids position between H3.3 and the canonical H3 are indicated. 
Modified from Szenker et al., 2011. 
 
H3t is a testis specific replacement histone that evolved from H3.3. It has been 
shown that this histone is necessary for spermatogenesis. Nucleosomes 
containing H3t form an open chromatin structure22.The current knowledge on 
H3.X and H3.Y is very limited as they were identified relatively recently. 23. 
CENP-A is a histone replacement that can be found at centromeres. This 
variant replaces canonical H3 in a significant proportion of centromeric 
nucleosomes24. CENP-A plays a central role in the assembly of kinetochores 





3.5 Histone modifications 
Histone modifications are reversible chemical alterations of the histone 
proteins26. The first modification identified on histones was lysine acetylation in 
the early 1960s27. Since then a multitude of PTMs at different sites have been 
identified28–30 and numerous studies have focused in attempting to understand 
how these modifications are regulated and how to they influence chromatin 
structure and function31. 
In general, histone PTMs can be classified into two groups: histone tail 
modifications and globular domain modifications. Histone tail modifications were 
the first ones to be studied as they are significantly more abundant. Since the 
histone tails protrude from the nucleosome core and can interact with other 
nucleosomes, it was initially assumed that modifications on the tails could affect 
inter-nucleosome interactions and consequently affect chromatin structure. It is 
now known that most histone tail modifications act via recruiting or repelling 
specific binding proteins (or complexes).  
Globular domain PTMs, are often less abundant and their identification has only 
been possible with the advancement of mass-spectrometry (MS) techniques. 
Interestingly, the majority of the PTMs at the globular domain are located on the 
lateral surface of the histone octamer32,33, at positions where the histone 
octamer and the nucleosomal DNA are in direct or water-mediated contact, 
suggesting that they play an important role regulating nucleosome structure or 
stability34,35. Studies on different globular domain modifications have shown that 
these modifications can indeed affect the stability of the nucleosome by 
affecting intra-nuclear interactions or the interactions between the histone 




A “histone code” has been proposed, in which the combination of different N-tail 
modifications determines the binding of specific “reader proteins” to chromatin, 
regulating downstream effects39. According to the histone code hypothesis, the 
different combinations of tail modifications serve as a code that regulates the 
chromatin environment controlling e.g. gene expression. Since it was proposed, 
many studies have challenged the concept of a histone code. On one hand, the 
identification of reader proteins containing more than one chromatin binding 
domain, such as multiple bromodomains (BD) which recognize acetylation40, 
supports the idea that the binding of such proteins is dependent on the co-
existence of multiple modification39,41. On the other hand, evidence that histone 
PTMs can directly, without an intermediate reader protein, modulate chromatin 
structure opposes the idea of an rather indirect, reader mediated code42.  
 
3.6 Histone lysine acylations 
Acylations are PTMs on lysine residues that result from the addition of an acyl 
group, from an acyl-CoA donor, to the -amino group of the lysine side chain. 
Acylations alter the overall positive charge of the lysine side chain, resulting in a 
decreased affinity towards DNA30. The first acylation to have been identified, 
and most extensively studied, was lysine acetylation (figure 3.4B), which we will 
discuss in the next chapter. In addition to acetylation, in recent years a wide 
array of short-chain histone lysine acylations have been identified by MS-based 
approaches, including lysine propionylation, butyrylation, crotonylation, 
malonylation and succinylation (figure 3.4C-G)28,29,31,43. The addition of the 
different acyl groups to the lysine residue has different effects on the lysine: 
while acetylation, propionylation, butyrylation and crotonylation result in the 




succinylation lead to a complete reverse of charge from positive to negative30,44–
46.   
 
Figure 3.4 - Lysine acylations 
Chemical structure of the lysine residue carrying to modifications (A) and different acylations: acetylation 
(B), propionylation (C), butyrylation (D), crotonylation (E), malonylation (F) and succinylation (G). Modified 
from Lee, 201347. 
 
Acylations have become the topic of great interest due to the possibility that 
they might link epigenetics and cellular metabolism48. The acyl-CoA required for 
the formation of these marks are intermediates of metabolic pathways, such as 
the tricarboxylic acid (TCA) cycle. It has been suggested that acylation levels 
are closely related to the availability of the metabolic intermediates they derive 
from49.  While it has been shown that, to a certain degree, acylations can be 
established non-enzymatically, their enzymatic deposition is a far more efficient 
process. All identified acyl-transferases are enzymes that have been previously 
described as acetyl-transferases. Evidence suggests that the preference for one 
specific acylation over another depends on the specific affinity the enzymes 




3.6.1 Lysine acetylation 
Histone lysine acetylation is an abundant histone mark which neutralizes the 
positive charge of the -amino group of the lysine side chain (figure 3.4B). This 
results in the weakening of the interactions between the histones and the 
negatively charged phosphate group of the DNA (tails and globular domain) or 
the acidic patch of neighboring nucleosomes (in the case of the H4 tail), leading 
to the exposure of the underlying DNA52,53. Additionally lysine acetylation in the 
histones tails can be specifically bound by BD containing proteins54,55.  
In the course of this project, I focused on the study of three acetylations located 
on the lateral surface of the histone octamer, at lysines 56, 64 and 122 of 
histone H3 (H3K56ac, H3K64ac and H3K122ac). 
There are two main groups of enzymes that regulate histone acetylation: 
histone acetyl-transferases (HATs) and histone deacetylases (HDACs).  
Table 3.1 - Mammalian type A HAT subfamilies 
 
HATs are a group of enzymes that use acetyl-CoA (ac-CoA) and can catalyze 
the transfer of the acetyl group to the -amino group of the lysine side chain. 
They can be divided into two main classes: type A and type B. Type B HATs are 
highly conserved and can be mainly found in the cytoplasm, where they 
acetylate free histones, prior to their deposit in the chromatin56,57. Type A HATs, 
are a larger and more diversified group of enzymes, which can be subdivided 
Mammalian Type A HAT sub-families Examples 
GNAT KAT2A, KAT2B 
MYST MOF, MOZ, MORF, HBO1, TIP60 




into three sub-families according to their sequence and structure (table 3.1)58. 
HATs, in the majority of the cases, do not present specificity towards single 
lysine residues, instead they can acetylate multiple sites59. 
HDACs remove the acetyl group from lysine residues, restoring their positive 
charge. While HATs are predominantly associated with transcription activation, 
HDACs are generally associated with transcriptional repression. HDACs have 
relatively low substrate specificity and a single enzyme can deacetylate several 
sites. HDACs can be classified into four classes: I, II, III and IV60.  
Class I is composed of enzymes related to the yeast scRpd3 and its members 
are exclusively found in the nucleus.  HDACs class II is composed of enzymes 
similar to the yeast enzymes Hda1 and can be found both in the nucleus and 
cytoplasm. HDAC11 is the only member of class IV and little is known about this 
enzyme61.  Class III, commonly referred to as sirtuins, differs from the rest as 
they require a specific co-factor, NAD+27. Sirtuins can be found in the nucleus, 
cytosol and/or mitochondria60.   
Table 3.2 - Human HDAC classes 
HDAC classes Membranes of the class 
Class I HDAC 1-3 and 8 
Class II HDAC 4-7 and 9-10 
Class III Sirtuins 1-7 
Class IV HDAC11 
 
3.6.2 Lysine succinylation 
Lysine succinylation was described for the first time in 201162 and soon after the 
first histone lysine succinylations were identified (figure 3.5)63. Interesting the 




domain of the core histones, suggesting this modification could directly regulate 
chromatin function.   
 
Regarding the removal of this mark, it has been reported that sirtuins can have 
desuccinylase activity. Sirtuin 5 (SIRT5), a HDAC with very limited deacetylase 
activity, has been shown to have a preference towards negatively charged 
acylations, such as malonylation and succinylation64. SIRT5 is mainly found in 
the mitochondria, but can be found in smaller amounts in the cytosol and 
nucleus65. Sirtuin 7 (SIRT7), has been shown in vitro and in vivo to have 
desuccinylase activity in the nucleus66. 
 
3.7 Epigenetic regulation during transcription 
The organization of the DNA into chromatin constitutes a physical obstacle to 
gene transcription, as RNA polymerase II (RNA pol II) is prevented from 
accessing the DNA. Several mechanisms work simultaneously to regulate 
transcription. In an initial step, chromatin structure decondenses, resulting on 
the exposure of specific DNA regulatory regions, such as promoters and 
enhancers, to DNA binding factors. Specific epigenetic factors mark these 
regulatory regions (table 3.3) and, directly or through binding proteins, lead to 
Figure 3.5 – Known lysine succinylation sites on human core histones. 




the reduction of the nucleosome occupancy. Transcription factors and RNA pol 
II bind the chromatin to form the pre-initiation complex (PIC). Once transcription 
is initiated, new histone PTMs are established guaranteeing the DNA stays 
accessible while necessary (table 3.3). 
Table 3.3 - Summary of main histone PTMs signaling for active and inactive chromatin regions 
Chromatin state Location Signature marks 
Active 
Promoters H3K4me367; H3K9ac68; H3K14ac68 
Gene body H3K36me369 






The acetylation of lysine 56 on histone H3 was the first histone globular domain 
modification to be extensively characterized74. Lysine 56 is located near the 
entry and exit sites of the nucleosomal DNA, a region of the nucleosome where 
the DNA is weakly bound to the histone octamer (figure 3.6)26. Acetylation of 
H3K56 increases DNA breathing, a condition in which the DNA transiently 
unwraps from the histone octamer starting at the DNA entry and exit sites75.  
The majority of studies on this PTM were carried out in budding yeast, where it 
was initially identified. In yeast, Rtt109, together with the histone chaperon Asf 
establishes H3K56ac. Rtt109 can only acetylate free histones and as a result, 
H3K56ac is mainly established during S phase and largely disappears during 
G2/M phases76. Newly synthesized H3 histones are marked by this modification, 
which is necessary for nucleosome formation both during DNA replication and 




promoter nucleosomes, where it enhances nucleosome turnover. H3K56ac 
stimulated DNA breathing 42, is believed to result in  increased transcription. The 
deacetylation of H3K56 in yeast is mediated by two members of the sirtuin 
family, Hst3 and Hst478. 
In mammals, H3K56ac is a low abundant PTM (with an approximate abundancy 
of 28 %79 in yeast and 1 %80 in mammals), and there is no  specific HAT for this 
site. Three different enzymes can establish H3K56ac: p300, CBP and GCN581. 
Similarly, to yeast, in mammals sirtuins are responsible for the removal of this 
mark77. H3K56ac in mammals is not an S phase specific mark, and newly 
synthesized H3 are not marked by it77. Instead, H3K56ac has been shown to 
play a role in DNA damage response (its levels decrease upon DNA 








Figure 3.6 – Ribbon structure of the nucleosome. 
Lysines 56, 64 and 122 on histone H3 are highlighted in red. The nucleosomal DNA is indicated as 





Lysine 64 on histone H3 is the first amino acid of the 1 helix. It is positioned on 
the lateral surface of the histone octamer and is in water-mediated contact with 
the nucleosomal DNA84. Like H3K56, it is located in proximity to the entry and 
exit sites of the nucleosomal DNA (figure 3.6) although further in the 
nucleosome6.  
H3K64ac is an active chromatin specific PTM, which is enriched at active 
transcriptional start sites (TSS) and enhancers37. It has been shown that 
H3K64ac disrupts the nucleosome stability, facilitating histone eviction37. In 
addition to its genomic localization, time course studies suggested that  
H3K64ac at promoter and enhancers is involved in gene regulation37,85. 
p300/CBP are the main enzymes responsible for the establishment of this mark, 
but no eraser has been identified37. 
 
3.10 H3K122ac 
Lysine 122 on histone H3 is located near the nucleosome dyad axis (figure 3.6), 
the nucleosome region which coordinates the most internal segment of the 
nucleosomal DNA. It is at the dyad axis that the DNA and the histone octamer 
have the strongest interactions26,86. H3K122 is in water-mediated contact with 
the nucleosomal DNA84, and it has been shown that the substitution of lysine 
122 by an acetylation mimic (H3K122Q) leads to the destabilization of this 
contact87. p300/CBP36, as well as bromodomain protein 4 (BRD4), have been 





H3K122ac is enriched at active promoter and enhancers. Regarding its role at 
the promoter, H3K122ac can be detected early during gene activation and in 
vitro, this single modification can stimulate transcription by itself89. H3K122ac  
has been used to identify a new class of active enhancers, which are 
characterized by the co-presence of H3K4me1 with H3K64ac and/or H3K122ac 
and the absence of H3K27ac85. 
 
3.11 H3K122succ 
H3K122 succinylation has been identified recently29, however our 
understanding on the function and regulation of H3K122succ is still very limited. 
In an initial study on this PTM, it was shown that H3K122succ is regulated by 
SIRT7. SIRT7 can remove H3K122succ from chromatin in response to DNA 
break, leading to chromatin compaction66. Failure to desuccinylate H3K122 is 
associated with impaired homologous recombination and non-homologous end-
















The organization of the DNA into chromatin plays a crucial role in the regulation 
of all DNA dependent processes, including transcription. Among the known 
factors controlling DNA organization are histone modifications. These histone 
modifications can act both indirectly - by attracting or repelling specific 
chromatin-binding proteins - or directly - by modulating the intra- and inter-
nucleosome interactions or histone-DNA interactions90.  
With the recent advancement of MS techniques, novel, less abundant, globular 
domain histone PTMs have been identified. Interestingly, many of these 
modifications are acylations (including acetylation and succinylation), whose 
acyl-donor groups are intermediates of different metabolic pathways, suggesting 
that these modifications could link metabolism with  chromatin organization29. 
However, currently very little is known about the function of many of these 
acylations in the globular domain. 
In the first part of my thesis, my aim was to unravel the function of a novel 
histone modification, H3K122succ, in transcription. This modifications was of 
particular interest since lysine 122, located on the nucleosome dyad axis, forms 
a water-mediated salt bridge with the DNA backbone6. Acetylation of this 
residue disrupts this interaction leading to destabilization of the nucleosome and 
has been shown to stimulate transcription in vitro85,89. I hypothesized that the 
succinylation of this residue, due to the reverse of charge it imposes on the 
lysine’s side chain28 could lead to a possibly higher destabilization of the 
nucleosome and, likewise, affect transcription. 
For the second part of the project my aim was to explore possible synergistic 
effect between three described H3 globular domain acetylations: H3K56ac, 




our lab and others, to different extents, individually. The available data suggests 
they share genomic locations and might co-occur. All these three core 
acetylations have been associated with active regulatory regions in 
mammals42,81,89,91. I set out to investigate synergistic functions of these 
























5.1 Part 1 - H3K122succ 
5.1.1 Antibody purification and validation  
In order to be able to study the succinylation of H3K122, it was crucial to raise 
and carefully characterize antibodies that specifically recognize H3K122succ. 
This was necessary since the only commercially available H3K122succ 
targeting antibody failed to pass the validation process, as it clearly recognized 
several other H3 PTMs in peptide immunoblot (figure 5.1A).  We, therefore, 
immunized 14 rabbits with H3K122succ peptides and double affinity-purified 
antibodies from their serum.  Out of 14 immunizations, we successfully purified 
antibodies from 3 rabbit sera.  The first characterization step was a peptide 
immunoblot which confirmed the antibodies did not recognize a selection of 
other known PTMs (figure 5.1B-D). Next, we tested these antibodies in 
immunoblot on unmodified (un), H3K122succ and H3K122R recombinant 
octamers (rOctamers; figure 5.1E). The antibodies only detected the H3 band 
when H3K122 was succinylated (lane 1) and did not recognize the unmodified 
nor H3K122R mutant.  
Next, we tested the antibodies’ specificity in peptide competition, for which the 
antibodies were pre-incubated with peptides before being added to the 
nitrocellulose membranes onto which the histones had been transferred to. All 
antibodies recognized specifically H3 and this signal was only competed away 
by the H3K122succ peptide (figure 5.1F).   
Due to the high abundance of histone tail PTMs, to exclude that the antibody 
signal was caused by the recognition of modifications at the H3 N-terminal tail, 
chromatin was limited digested by trypsin in order to cleave the histone tails off 




recognized, in the sample that undergone partial trypsin digestion two bands 
































































































































































Figure 5.1 - Anti-H3K122succ antibody validation 
A Peptide dotblot array probed with the commercially available anti-H3K122succ antibody. B-D Peptide 
dotblot arrays probed with anti-H3K122succ antibodies #1, #2 and #3. Peptides with indicated 
modifications were dotted on membranes. E Immunoblotting analysis showing that only H3K122succ-
carrying rOctamers are recognized by the anti-H3K122succ antibody. Ponceau staining of histones is 
shown as a loading control.  F Peptide competition of H3K122succ immunoblot. H3K122succ antibody was 
pre-adsorbed with the indicated peptides. Only in the presence of the H3K122succ peptide was the signal 
competed away. G MNase digested chromatin (10 µg) was incubated at 26 °C for 10 minutes in the 
absence or presence of different quantities of trypsin (250, 500 and 1000 ng). The levels of H3K122succ 
were assessed by immunoblot. Ponceau staining of histones is shown as a loading control. H Immunoblot 
on native acid extracted histones from MCF7 that were incubated O/N with 20 mM of Nam. Ponceau 




It has been reported that  sirtuins can desuccinylate histones66. Therefore, we 
treated MCF7 cells overnight (O/N) with nicotinamide (Nam) a sirtuin inhibitor 
and asked if this increases the H3K122succ signal (figure 5.1H). Indeed, the 
immunoblot signal on H3 from Nam treated samples was stronger than the 
untreated control samples. Altogether these results confirmed the quality of the 
antibody, validating it as a reliable tool to study H3K122succ. 
 
5.1.2 Distribution of H3K122succ on histone variants 
As mentioned in the introduction chapter, H3 has several variants in 
mammals18. The main somatic variants are the canonical H3 and H3.3. In 
general, canonical H3 is found throughout chromatin, while H3.3 is enriched at 
active sites with a high turnover of nucleosomes, such as promoters and 
enhancers92. In order to understand if H3K122succ was enriched at specific H3 
variants we compared H3K122succ levels on H3.1 and H3.3. For this, we 
collected histone acid extracts from HEK293 cells ectopically expressing H3.1 
or H3.2 carrying a HA/FLAG-tag and probed on immunoblot for H3K122succ 
(figure 5.2). Our results revealed that H3K122succ is enriched on H3.3 when 
compared to H3.1.  
 
Figure 5.2 - H3K122succ is enriched on H3.3 compared to H3.1 
Histones were acid extracted from approximately 20x106 HEK293 cells ectopically expressing H3.1 or H3.3 
carrying an HA/FLAG-tag. The levels of H3K122succ were assessed by immunoblotting. Anti-FLAG blot is 




5.1.3 Distribution of H3K122succ in chromatin 
In order to gain a comprehensive understanding of the genomic distribution of 
H3K122succ, we performed chromatin immunoprecipitation followed by 
massive DNA parallel sequencing (ChIP-seq) in MCF7 cells. The analysis of the 
data was performed by Stephanie Le Gras at the Institut de Génétique et de 
Biologie Moléculaire et Cellulaire (Strasbourg, France). All three validated anti-
H3K122succ antibodies were used for this experiment. The peaks from the 
three anti-H3K122succ samples were compared using TODO1 and the results 
revealed there is a very high-overlap between them (figure 5.3A). 
 
Figure 5.3 - ChIP-seq results show H3K122succ is enriched at the TSS 
A Scatter plot showing the peak correlation between purified anti-H3K122succ antibodies 1-3. B Pie chart 
displaying the relative distance of the H3K122succ peaks relative of the TSS. Peaks were annotated with 
HOMER and Ensembl database v94 (for human genome hg38).  C Heatmap comparing the H3K122succ 
peaks from the three samples. The peaks were aligned to the TSS (± 5000 bp). D Average profile at the 




To characterize the genomic distribution of H3K122succ the peaks were 
annotated using HOMER and the Ensembl database v94. Approximately 50 % 
of all peaks are located in the proximity of TSSs, suggesting an enrichment of 
H3K122succ at promoter regions (figure 5.3B). Next we plotted all H3K122succ 
peaks in a ± 5 kb window around the TSS. Interestingly, the results revealed a 
single peak overlapping the TSS, in a region often referred to nucleosome-free 
region (NFR) where the nucleosome occupancy is decreased93 (figure 5.3C). 
 
5.1.3.1 H3K122succ is associated with open chromatin 
To further understand the distribution of H3K122succ in the genome, we 
compared the H3K122succ peaks with formaldehyde-assisted isolation 
of regulatory elements sequencing (FAIRE-seq) and DNase I hypersensitive 
sites sequencing (DNase-seq) datasets on MCF7 (figure 5.4). These two 
methods assess chromatin accessibility.  
 
Figure 5.4 – H3K122succ is associated with open chromatin regions 




In short, FAIRE-seq relies on the different biochemical properties between 
protein-bound (compact) and protein-free (open) DNA to separate them94, while 
DNase-seq is based on the premises that open chromatin regions are more 
susceptible to cleavage by DNase I95. As shown in figure 5.4, H3K122succ 
peaks have a clear overlap with both FAIRE-seq and DNase-seq, suggesting 
H3K122succ is associated with open chromatin regions as expected for an 
active chromatin mark. 
 
5.1.3.2 H3K122succ correlates with active transcription 
The data suggest a correlation between H3K122succ and an active transcription 
state. To further explore this, we compared the levels of H3K122succ with gene 
expression levels. For this we clustered all genes into four groups according to 
their steady-state mRNA levels: Q1 corresponds to the 25 % least expressed 
genes and Q4 to the 25 % highest expressed genes (figure 5.5A).  The results 
revealed that H3K122succ is particularly enriched on highly expressed genes 
and that enrichment levels correlate with gene expression. 
Next, we compared the levels of H3K122succ and H3K4me3 (a mark for active 
TSS) in all TSS (figure 5.5B), revealing a strong correlation between 
H3K122succ and H3K4me3 enrichments at active genes. Plotting the 
enrichments overs transcribed TSS demonstrates that H3K122succ peaks co-






Figure 5.5 - H3K122succ is associated with known active histone marks and to active transcription 
A Metagene plot displaying the distribution of H3K122succ around the TSS according to its quartile of 
expression. B Heatmap showing the proportion of TSS regions with H3K122succ, H3K4me3 and the 
corresponding mRNA expression.  
 
5.1.4 p300/CBP is a succinyltransferase for H3K122 
As mentioned in the introduction chapter, it has been shown that HATs can act 
as succinyltransferases96. In order to identify the enzyme(s) responsible for the 
establishment of H3K122succ a selection of HATs known to act as 
succinyltransferases was considered, including KAT2B, p300 and CBP.  
 
5.1.4.1 Knockdown of candidate succinyltransferases 
To identify the succinyltransferase(s) responsible for the succinylation of lysine 
122 on histone H3, we depleted selected of HATs from MCF7 cells by short 
interfering RNA (siRNA) and quantified the relative of the levels of H3K122succ 





Figure 5.6 - The double knockdown of p300/CBP leads to the decrease in the levels of H3K122succ 
A Representative immunoblot displaying the levels of H3K122succ upon siRNA depletion of various HAT 
enzymes. Ponceau staining of histones is shown as a loading control.  B Histone acetyltransferases 
(pCAF, p300 and/or CBP) were depleted from MCF7 cells by siRNA. The bar graph shows the average  
standard deviation (STD) of H3K122succ levels, relative to the scramble siRNA control, of two biological 
replicates. C The levels of RNA expression of p300 and CBP upon siRNA KD were measured by qPCR. 
 
While the knockdown of KAT2B did not lead to a decrease of H3K122succ, the 
individual depletion of p300 and CBP led to a slight decrease in the levels of this 
modification (figure 5.6A-B). Since p300 and CBP share a high sequence 
homology97, in order to exclude that the relatively small effects of the individual 
depletion of these enzymes were not due to compensation by the other, a 
double knockdown of p300/CBP was performed. As it is shown in figure 5.6B, 
the double depletion of p300 and CBP led to a higher decrease in the 
H3K122succ levels (approximately 55 % comparing to the siRNA control). We 
compared the p300 and CBP mRNA levels upon the individual and double 






































































































the mRNA levels of p300 and approximately 50 % of the mRNA levels of CBP 
were kept, possibly explaining why no stronger effects on the H3K122succ 
levels were observed (figure 5.6C).  
 
5.1.4.2 In vitro succinyltransferase assay on short peptides 
To confirm that the paralogues p300 and CBP can indeed establish 
H3K122succ, we performed succinyltransferase assays on peptides spanning 
the region around lysine 122 on histone H3. For this we expressed and purified 
full length p300 in Sf9 cells (more details on section 8.2.22). We incubated H3 
peptides with increasing amount of p300 in the presence of [14C]suc-CoA and 
quantified the radioactivity incorporated by liquid scintillation counting (figure 
5.7). In agreement with the results from the knockdown results, the in vitro 
succinyltransferase assays confirmed p300 as an enzyme that can establish 
H3K122succ. 
 
Figure 5.7 - In vitro succinyltransferase assay on peptides 
In vitro succinyltransferase assay on peptides spanning H3K122.  Samples were incubated overnight with 
different concentrations of p300 (0 to 160 ng) in the presence of [14C]suc-CoA. The radioactivity 
incorporated in the peptides was quantified by liquid scintillation counting. The bar graph displays average 





5.1.4.3 In vitro succinyltransferase assay on recombinant octamers 
To further support the evidence that p300/CBP can act as succinyltransferases 
for H3K122succ, we carried out a second type of in vitro succinyltransferase 
assays on recombinant wild type histone octamers as substrates. For this 
assay, recombinant octamers were incubated O/N at 30 °C, with p300 in 
absence of any co-enzyme or suc-CoA and immunoblotting was used to 
determine H3K122succ levels (figure 5.8).  
As shown in figure 5.8, the results demonstrated that p300 is a 
succinyltransferase for H3K122succ.  
 
Figure 5.8 - p300 can establish H3K122succ on octamers in vitro 
In vitro succinyltransferase assay, on recombinant unmodified histone octamers as substrate. After 
incubation with p300 and suc-CoA, the levels of H3K122succ were assessed by immunoblot. Ponceau 
staining of histones is shown as a loading control. 
 
5.1.5 Sirtuin 5 can remove H3K122succ 
Sirtuins have been shown to act as deacylases, in particular SIRT5 and SIRT7 
have shown to act a desuccinylases66,98. For SIRT7, but not for SIRT5, it been 
reported that it can specifically remove H3K122succ98. To address the possible 
involvement of SIRT5 in the removal of H3K122succ, in vitro and in vivo assays 






5.1.5.1 In vitro desuccinylase assay 
To explore a potential role of SIRT5 in the removal of H3K122succ, we 
performed in vitro desuccinylase assays on H3K122succ peptides using 
recombinant SIRT5 and SIRT7 (figure 5.9). As expected, we found that SIRT7 
can desuccinylate H3K122succ. Additionally, the results revealed that SIRT5 
can also desuccinylate H3K122succ in vitro. 
 
Figure 5.9 - SIRT5 can desuccinylate H3K122succ in vitro 
A-B In vitro desuccinylase assay on H3K122succ peptides. Unmodified H3K122 peptide was used as 
control. Peptides were probed with H3K122succ antibody after incubation with sirtuins. Note that only in 
the co-presence of SIRT7 or SIRT5 and NAD+, the levels of H3K122succ decreased. 
 
5.1.5.2 SIRT5 acts as a H3K122succ desuccinylase in vivo 
To confirm the activity of SIRT5 in vivo,  we compared  the levels of 
H3K122succ on histones extracted from wild type (WT) and Sirt5-knockout (KO) 
mouse embryonic fibroblasts (MEFs64) by immunoblot (figure 5.10).  
 
Figure 5.10 - SIRT5 acts as H3K122succ desuccinylase in vivo 
H3K122succ levels in Sirt5-KO cells. Histones were acid extracted from WT and Sirt5-KO MEFs and levels 




H3K122succ in WT and Sirt5-KO MEFS. Coomassie staining of histones is shown as a loading control. B 
Quantification of H3K122succ levels. Average and STD of two independent experiemnts are shown. 
 
In agreement with the in vitro desuccinylase assays, levels of H3K122succ were 
higher on histones extracted from the Sirt5-KO MEF cell line compared to WT 
MEFs. These results confirm, therefore, that SIRT5 can act as H3K122succ 
desuccinylases. 
 
5.1.6 Reconstitution of recombinant chromatin 
To investigate the effect of H3K122succ on transcription in a well-controlled 
setup, we decided to perform in vitro transcription on chromatinized templates 
with unmodified H3 or site-specifically succinylated at H3K122.  
 
5.1.6.1 Reconstitution of WT and H3K122succ histone octamers 
Tag-less WT H2A, H2B and H4 were expressed on E. coli and purified from 
inclusion bodies as described in section 8.2.14. H3K122succ and WT H3 were 
generated by protein synthesis (Almac, UK). To assemble recombinant 
octamers, we mixed the core histones in equal molar amounts and processed 
them as described in section 8.2.15. Two types of histone octamers were 
assembled, one unmodified on H3 and another carrying fully succinylated H3 at 
lysine 122. After assembly, the octamers were successfully separated with a 





Figure 5.11 - Purification of histone octamers by gel filtration 
Recombinant histones core histone including wild type H3 or H3K122succ were refolded as described in 
the methods section, concentrated and loaded on a Superdex200 increase gel filtration column. The upper 
panels show the UV elution profile from the Superdex200 increase column for histones refolded with A WT 
H3 or B H3K122succ. The peak fractions were analyzed by SDS-PAGE and coomassie stained (bottom 
panels). The fractions containing all four histones in stochiometric amounts (28-31) were pooled, 
concentrated to 2 mg/ mL and stored at -20 °C in refolding buffer with 50 % glycerol. 
 
5.1.7 In vitro transcription 
The in vitro transcription assay is an elegant experiment designed to 
recapitulate all major steps of eukaryotic transcription in a cell free assay. It is 
composed of three main steps: chromatin assembly, sucrose gradient 
purification and the in vitro transcription assay per se (figure 5.12). 
 
Figure 5.12 - In vitro transcription assay summary 
Schematic representation of the in vitro transcription assay: chromatin assembly, density selection by 





The assay requires several components including a DNA template (which can 
consist of free or chromatinized DNA) containing a promoter and a transcription 
activator binding site; a transcriptional activator protein; a source of Pol II, 
transcription factors and mediator complex and ribonucleotide tri-phosphates 
(rNTP). For the purpose of this thesis, we used as DNA template the previously 
described pG5-MLP99, an approximately 5 Kb plasmid containing a viral 
promoter (major late promoter, MLP), downstream of five GAL4-binding 
domains (where the activator protein will bind) and upstream of a 380 bp G-less 
cassette, which will serve as a template for the transcript.  
 
 
Figure 5.13 - Regulatory region of PG5-MLP 
Schematic representation of the regulatory region of the DNA template used on the in vitro transcription 
assays. The template includes five GAL5-binding domain, one major late promoter and an approximately 
380bp G-less cassette. 
 
The use of a transcriptional activator is required for assays using chromatinized 
templates, as chromatin inhibits transcription. For that purpose, we used 
recombinant viral VP16, fused to GAL4 (GAL4-VP16).  HeLa nuclear extracts, 
prepared as described in methods 8.2.23, were used as a source of Pol II, 
transcription factors and mediator complex. Adding radiolabeled rUTP-32P in 
the rNTP mix, allows the quantification of the transcript amount produced in 
each assay. The purity of all components was checked on SDS-page followed 





Figure 5.14 - Purity control of the reagents used for the in vitro transcription 
SDS-PAGE and coomassie staining of A WT and H3K122succ histone octamers, B NAP1, C ACF and D 
GAL4-VP16. E Agarose gel electrophoresis of pG5-MLP plasmid. 
 
5.1.7.1 Chromatin assembly 
The reconstitution of chromatin can be accomplished through gradient salt 
dialysis (from high to low concentrations of salt) of histone octamers and DNA or 
through ATP-dependent assembly by a histone chaperone and a chromatin 
remodeling complex. While chromatin assembly by salt dialysis results in 
random distribution of nucleosomes, ATP-dependent assembly results in the 
periodically distribution of nucleosomes. Since the latter resembles chromatin 
structure in vivo, we chose it for the in vitro transcription assays. Histone 
chaperone nucleosome assembly protein (NAP1) and chromatin remodeler ACF 
were expressed in Sf9 cells infected with baculovirus and purified as described 
in the methods chapter. For each chromatin assembly, we tested different ratios 




Chromatin assembly efficiency was assessed by MNase mapping (methods 
8.2.19) followed by agarose gel electrophoresis and ethidium bromide (EtBr) 
staining (figure 5.15). Preliminary assays showed that for both WT and 
H3K122succ chromatin, a histone octamer to DNA ratio of 1:1 led to the best 
resolved MNase mapping and was thus chosen for the assembly. 
 
Figure 5.15 - Chromatin assembly by NAP1 and ACF 
Agarose gel electrophoresis, followed by ethidium bromide staining of MNase digested assembled 
chromatin. On the left lane, no MNase was added to the incubation as a digestion control. On the second 
left, no histone octamers were added to assembly reaction.   
 
5.1.7.2 Sucrose gradient 
After assembly, we fractionated the chromatin by sucrose gradient 
centrifugation. The migration of chromatin through the gradient is dependent on 
the speed and length of the centrifugation, as well as the density of the 
chromatin. Under similar conditions, chromatin will migrate through the gradient 
according to its compaction. The selection of the same fractions, allows 
therefore, an increase in the homogeneity of different batches of chromatin 





Figure 5.16 - Sucrose gradient purification of recombinant chromatin 
Sucrose gradient centrifugation of WT (top) and H3K122succ (bottom) chromatin. The red box marks 
fractions 6-8, that were pooled together and dialyzed in BC50 prior to in vitro transcription assays. 
 
5.1.7.3 In vitro transcription assays on chromatin  
In vitro transcription assays were performed in collaboration with Raphael 
Margueron at the Institut Curie (Paris, France), where we performed initial 
assays before establishing them in the laboratory of Robert Schneider.  
 
5.1.7.3.1 Suc-CoA stimulates transcription in vitro 
First to understands if suc-CoA can stimulate transcription (as ac-CoA does), 
performed in vitro transcription assays on unmodified chromatin in the presence 
of suc-CoA and compared the results to the levels of transcription in the 
absence of co-enzymes or in the presence of ac-CoA (figure 5.17).  
 
Figure 5.17 - Suc-CoA can stimulate transcription in vitro 
A In vitro transcription in the presence of GAL4-VP16 and p300 in the absence of co-enzymes, presence of 
ac-CoA and suc-CoA. Shown is a representative audioradiogram. B Quantification of in vitro transcription 
reactions as in A. Expression relative to no CoA is plotted. Average and STD of two independent 




The results shown in figure 5.17, suggest that suc-CoA can stimulate 
transcription, to a similar degree to ac-CoA. 
 
5.1.7.3.2 H3K122succ increases transcription in vitro  
In order to study the impact of H3K122succ on transcription, we performed in 
vitro transcription assays on WT and H3K122succ chromatin.  Remarkably, the 
presence of H3K122succ stimulated transcription (compared to unmodified 
chromatin) by approximately 1.6-fold (figure 5.18).  
 
Figure 5.18 - H3K122succ increases transcription in vitro 
A In vitro transcription on unmodified chromatin or H3K122suc chromatin. Shown is a representative 
audioradiogram. B Quantification of reactions. Expression relative to transcription on unmodified chromatin 
is plotted. Average and STD of two independent experiments are shown. 
 
5.1.8 H3K122succ affects nucleosome stability in vitro 
In order to gain insight in a potential mechanism how H3K122suc might 
simulate transcription we asked next whether H3K122succ affects nucleosome 
stability. For this we performed single molecule Fluorescence Resonance 
Energy Transfer (smFRET) assays. These assays were carried out by Mariska 




Mono-nucleosomes were assembled (from WT and H3K122succ octamers) by 
salt dialysis onto a modified MMTV-A DNA positioning sequence100, carrying 
two fluorescent dyes at positions F48 and R28. This method allows the 
comparison of the kinetics of nucleosome salt-induced disruption of WT and 
H3K122succ nucleosomes (figure 5.19A). 
 
Figure 5.19 - H3K122succ contributes to the destabilization of nucleosomes  
A Schematic representation of the smFRET assays. B Mean fraction of bursts in the nucleosome 
population (proximity ratio >0.35) of WT (black) and H3K122succ (red) plotted against different NaCl 
concentrations. Three measurements were performed for each salt concentration. The data were fitted 
to 𝑓(𝑥) = 𝐴2 +
𝐴1−𝐴2
1+𝑒(𝑥−𝑥0) 𝑑𝑥⁄
 where A2 was restricted to a minimum of zero.   
 
The results revealed that under low salt concentrations (below 0.3M) unmodified 
and H3K122succ nucleosomes showed a similar stability. However, 
nucleosomes carrying H3K122succ were more sensitive to destabilization upon 
increased salt concentrations (from 0.3M; figure 5.19B). This assay 
demonstrates that H3K122succ can indeed destabilize nucleosomes and 
reveals a potential mechanism how H3K122suc can stimulate transcription. 
 
5.2 Part 2 – Histone H3 core domain acetylations 
In the second part of my thesis I wanted to investigate if multiple lateral surface 
modifications are acting synergistically. For this I focused on the acetylations of 




5.2.1 In vitro transcription on recombinant chromatin 
To understand the potential synergistic role of H3K56ac, K64ac and K122ac in 
transcription, we performed in vitro transcription assays, as described on 
section 8.2.24. For these assays, we expressed and purified wild type and site-
specifically modified recombinant histones from E. coli. For the expression of 
acetylated histones, an amber suppression system was used. 
 
5.2.1.1 Optimization of the amber suppression system 
Several variations of amber suppression systems have been described42,101,102. 
In general, these approaches rely on two essential components: a modified 
protein coding sequence, in which the codon where the modified amino acid to 
be inserted is substituted by an amber codon (TAG), and an evolved orthogonal 
transfer RNA (tRNA)/aminoacyl tRNA synthetase pair (figure 5.20). The amber 
codon is the least frequent STOP codon in E. coli103. In amber suppression 
systems, during translation this codon is recognized by the modified tRNA 
leading to the incorporation of an acetyl-lysine (AcK) by the aminoacyl tRNA 
synthetase101.   
 
Figure 5.20 - Amber suppression system 
Schematic representation of the recombinant expression of site-specifically modified histones in E. coli 
strain BL2. Bacteria transformed with the plasmid(s) carrying the components of this amber suppression 
system are supplemented with Nam and acetyl-lysine. Histone expression is induced with IPTG.  After 
being expressed, histones are purified and mixed with other core histones to assemble octamers and later 




While this method has been successfully used to express histones fully 
acetylated at a single site, it presented serious limitations for the expression of 
multiple-site acetylated proteins. During translation two parallel mechanisms 
compete with each other. The first one, is naturally occurring and regards the 
recognition of the amber codon by release factor 1 (RF1), which recognizes 
UAG as a STOP codon and promotes the release of the nascent peptide104,105. 
The second mechanism, consists on the already described amber suppression 
system. We estimate that in the initial amber suppression systems 1:50 of all 
expressed proteins is full length and includes the intended modification. The 
remaining 49:50 consist of truncated proteins at the corresponding site of the 
amber codon. Considering this rate, for the expression of a protein carrying 
three acetyl-lysines, approximately 1:125000 expressed proteins would be full 
length, making it inadequate for this purpose.  
In a first attempt to improve the efficiency of the system, we compared  different 
E. coli strains: BL21, JX33106 and C321.A107. The latter two strains carry a KO 
of RF1 in order to decrease the levels of histone truncation during translation108. 
In addition, C321.A has all naturally occurring amber codons substituted into 
ochre codons (UAA). As expected, the amounts of full-length modified histones 
produced in these strains increased, however both strains presented significant 
growth defects (data not shown) which hindered their use and prompted us to 
search for alternative improvements where we could use the BL21 strain.  
It has been reported that the overexpression of the C-terminal domain of L11 
(L11C) - a small, highly conserved ribosomal protein that is involved in RF1-
mediated peptide release – leads to high amber suppression, with nearly regular 
protein translation efficiency and normal growth rate109. Thus, we tried 




the incorporation of acetyl-lysine110 and substituted the promoter of the tRNA 
synthetase from a GlnRS promoter to a Trc promoter, a change that has been 
reported to increase the expression of the tRNA synthetase and consequently 
the efficiency of the system111. 
 
Figure 5.21 - Optimization of the amber suppression system 
Total protein extract after H3K122ac expression under different conditions was loaded on an SDS-PAGE 
gel and coomassie stained (top panel) or immunoblotted against anti-H3K122ac (bottom panel). Red 
boxes indicate the highest expression of the modified H3. 
 
To test this optimized amber suppression system and to determine the optimal 
growth conditions, we applied it first for the expression of single acetylated H3 
histones at lysine 122.  Different media and IPTG concentrations were tested. 
As shown on figure 5.21, we were able to express H3K122ac protein at 
relatively high levels when using the system in BL21 cultured in twice 
concentrated lysogeny broth (2x LB), with an optimal yield when protein 
expression was induced at a low IPTG concentration (0.05 mM) O/N at 20 °C. 
 
5.2.1.2 Expression and purification of acetylated histones 
Having now the tools to produce site-specifically acetylated histones, we 




H3K56ac, H3K64ac, H3K122ac, H3K56acK64ac, H3K56acK122ac, 
H3K64acK122ac and H3K56acK64acK122ac. After the expression of each 
histone, we controlled by immunoblotting that the expressed H3 histones carried 
the intended acetylations (figure 5.22). 
 
Figure 5.22 - Expression of single, double and triple-acetylated H3 
Immunoblots controlling for the expression of representative single, double and triple-acetylated histone 
H3. Expressed histones were blotted with antibodies against the specific acetylations to control for the 
correct insertion of acetyl-lysine and with anti-H3 C-terminal antibody to control for the full-length histone. A 




After expression of the modified histones, we purified them from inclusion 
bodies as described in section 8.2.14. We used two chromatography columns, a 
cation exchange and a gel filtration column, to separate the acetylated full-
length histones from the truncated ones. It was, however, not possible to 
separate the H3 truncated lysine 122 from full-length H3, since their elution 
profiles from both columns were very similar. Additionally, due to the nature of 
the system, in order to express sufficient quantities of each modified histone, 
large volumes of BL21 were cultured (2 L of culture yield approximately 9mg of 
WT H3; 5L of culture yield 1-2 mg of mono-acetylated H3; 10 L of culture and 
yield approximately 1 mg of double-acetylated H3 and 20 L of culture yield 




purification of the modified histones due to the relative higher abundance of 
DNA and contaminating proteins in the inclusion bodies (figure 5.23).  
 
Figure 5.23 - Expression and purification of acetylated H3 histones 
H3 histones were extracted from inclusion bodies as described in 8.2.14. Extracted histones were purified 
on a gel filtration and on a cation exchange chromatography column. The eluted fractions from the cation 
exchange chromatography column of A WT, B H3K64ac, C H3K56acK64ac and D H3K56acK64acK122ac 
were loaded on an SDS-PAGE gel and coomassie stained. The red boxes indicate the correct H3 bands. 
 
Since it has been described that the 3 helix of H3 is necessary for 
octamer/nucleosome formation112, H3 truncated at e.g. K122 is not able to form 
octamers. Therefore, the octamer reconstitution provided an additional step to 
separate the unwanted truncated histones, from the full-length ones. 
 
5.2.1.3 Reconstitution of modified histone octamers 
To assemble the differently acetylated histone octamers, equimolar quantities of 
each core histone were mixed as described in section 8.2.15. After assembly, 
the histone octamers were purified on a Superdex200 increase gel filtration 




the octamer reconstitution decreased proportionally to the increase in the 
number of acetylation sites. This could be due to a combination of several 
factors, including: the higher concentration of protein contaminants, higher 
proportion of truncated histones or simply due to the presence of higher amount 
of core acetylations in H3. 
 
Figure 5.24 - Purification of acetylated histone octamers by gel filtration 
Recombinant histones were refolded as described in 8.2.15, concentrated and purified on a Superdex 200 
increase gel filtration column. Displayed are representative chromatograms displaying the UV elution 
profile of A WT H3, B single acetylated H3 (H3K64ac), C double acetylated H3 (H3K56acK64ac) and D the 
triple acetylated H3 (H3K56acK64acK122ac). 
 
Despite the relatively low efficiency, we succeeded in assembling sufficient 





Figure 5.25 - Purified histone octamers 
The purity of the recombinant histone octamers was assessed by SDS-PAGE and stained with coomassie. 
 
5.2.1.4 Recombinant chromatin assembly for in vitro transcription  
Next, we assembled differently modified chromatin arrays for the in vitro 
transcription assays. As mentioned on Part I of the results, for the assembly of 
chromatin for in vitro transcription we relied on the use of the histone chaperon 
NAP1 and the ATP-dependent chromatin remodeler ACF, which guaranteed a 
regular spacing between the nucleosomes.  
 
Figure 5.26 - Chromatin assembly with different octamers by NAP1 and ACF 
Agarose gel electrophoresis and EtBr staining of assembled chromatin on pG5-MLP with eight different 
histone octamers: WT H3, H3K56ac, H3K64ac, H3K122ac, H3K56acK64ac, H3K56acK122ac, 
H3K64acK122ac and H3K56acK64acK122ac by NAP1 and ACF. Nucleosome positioning was assessed 





The efficiency of the assembly was assessed by partial MNase digestion (figure 
5.26). As it can be observed, the efficiency of the chromatin assembly was not 
homogeneous, namely H3K56acK64ac and H3K56acK122ac chromatin was 
more sensitive to MNase digestion. In order to compensate for different 
chromatinizations, we purified the different types of chromatin via sucrose 
gradients as described on 8.2.18 and fractionated them according to their 
migration in the gradient. Similarly-compacted chromatin was selected by the 
pooling of the same fractions (figure 5.27).  
 
Figure 5.27 - Chromatin purification on a sucrose gradient 
Sucrose gradient centrifugation of the eight chromatin assembly reactions was collected in 12 fractions of 
which 10 µL were analyzed by agarose gel electrophoresis and ethidium bromide staining. Fractions 4-6 
were pooled together and dialyzed against BC50 buffer. 
 
After pooling fractions 4-6 together, the samples were dialyzed against BC50 




5.2.1.5 In vitro transcription assays  
To investigate possible synergistic functions of the different H3 core 
acetylations, we next carried out in vitro transcription assays on WT and site-
specifically acetylated chromatin. The assays were performed as previously 
described. Initially we tested the effect of the single acetylations on chromatin 
using 40 ng of p300 per reaction. Interestingly, all three acetylations (H3K56ac, 






Figure 5.28 - In vitro transcription on WT and single acetylated chromatin in the presence of 40 ng of p300. 
In vitro transcription with 50 ng of purified chromatin in BC50. 40 ng of p300 were used and 50 ng of GAL4-
VP16 were added as indicated. Autoradiogram is shown. Transcription was quantified densitometrically 
using ImageJ. The results indicated on the bottom of the figure are presented, as relative to WT chromatin. 
 
We hypothesized that the mild effects we were observing were due to the high 
concentrations of p300 used. To test this hypothesis, we performed in vitro 
transcription assays on WT and single acetylated chromatin (H3K64ac) in the 
presence of decreasing amounts of p300 (data not shown). As expected, the 
transcript signal on the WT chromatin decreased proportionally to the decrease 
of p300. Interestingly, however, the level of transcription with the H3K64ac 
chromatin did not seem to be significantly affected by the lower amount of p300. 




with lower amounts of p300 the effects of the acetylations would be 
accentuated.  
We proceeded to repeat the in vitro transcription assays on WT and single 
acetylated chromatin in the presence of 2.5 ng of p300 (figure 5.29). As we had 
hypothesized, the use of lower amounts of p300 in the assay, led to a significant 
increase on the relative effects of the single acetylations, with the acetylation of 
lysine 122 on histone H3 stimulating transcription by 2.84-fold. 
 
Figure 5.29 - Single core acetylations can stimulate transcription in vitro 
In vitro transcription assays were carried out on 50 ng of chromatin, in the presence of 50 ng of GAL4-
VP16 and 2.5ng of p300. Transcription was quantified densitometrically using ImageJ relative to WT 
chromatin. 
 
Next, we wanted to understand how the different combinations of globular 
domain acetylations affected transcription. As expected, the combination of two 
acetylations led to a higher stimulation of transcription than the single 
acetylations (figure 5.30), with the two combinations carrying H3K122ac having 
the highest transcription levels, leading to a striking increase of approx. 4.2-fold. 
Interestingly, the combination of the three acetylations did not lead to a higher 


























Figure 5.30 - Double and triple acetylations on H3 lead to a higher stimulation of transcription in vitro 
In vitro transcription assay on chromatin carrying different combinations of H3 core acetylations. Assays 
were carried out on 50 ng of chromatin, in the presence of 50 ng of GAL4-VP16 and 2.5 ng of p300. 
Transcription was quantified densitometrically using ImageJ and is presented relative to WT chromatin. 
 
 
Altogether, these results show that histone core acetylations stimulate 
transcription in vitro and that combinations of acetylations lead to a higher 
stimulation. Direct effects of H3K56ac and H3K64ac on transcription had never 
been shown before. Additionally, these results suggest that the effect the 
modifications have on transcription are site-specific hinting a specific 
mechanism for each modified chromatin.  
 
5.2.2 The role of H3 core acetylations in vivo 
In order to be able to study the role of H3K56ac, H3K64ac, H3K122ac and their 
combinations in transcription in an in vivo system, we generated a mammalian 
cellular system where the effects of these modifications can be investigated. 
This model relies on the use of amino acid substitutions to mimic unmodified 
and acetylated histones lysine residues. Amino acid substitutions have long 
been used as an approach to study protein PTMs, as certain residues due to 




residues87,113. As an example, the replacement of a lysine residue by arginine 
(K>R) is commonly used to mimic the unmodified lysine state, while the 
substitution of a lysine residue by glutamine (K>Q) is often used to mimic lysine 
acetylation. 
Histone variant H3.3 has been shown to be enriched at the promoter and gene 
body of actively transcribed genes in euchromatin92, making it a relevant variant 
in the study of active H3 PTMs. Additionally, H3K122ac and H3K64ac had been 
shown to be enriched at H3.3. In mice, H3.3 is encoded by two genes, H3f3a 
and H3f3b, located on chromosomes 1 and 11 respectively114. 
Table 5.1 - List of mES cells used in this study. 
mES cell mutants Mimic state 
ESW26 Original cell line 
H3.3B H3f3a-/- H3f3b-/+ cell line 














For the generation of our in vivo model, starting from the mouse embryonic stem 




(H3f3a-/-H3f3b-/+) using the Clustered Regularly Interspaced Short Palindromic 
(CRISPR) genome editing system (H3.3B). Next, the remaining H3.3 coding 
gene was replaced by a mutated H3.3 gene containing two HA tags and site-
specific mutations (table 5.1). For the purpose of this work, a cell line containing 
a single 2HA-tagged H3.3 allele, carrying no amino acid substitution 
(2HA.H3.3B) will be considered our WT (non-mutated) control. 
These cell lines were created by two former laboratory members Dr. Nithyha 
Parameswaran Kalaivani and Dr.  Sylvain Daujat. 
 
5.2.2.1 Analysis of the effect of H3.3 core acetylation on steady state 
transcription 
In order to investigate the effects of these H3 core acetylations at the 
transcriptional level in vivo, we cultured the mES cell lines under standard 2i/ 
LIF conditions and extracted and purified total RNA from them. Purified RNA 
was sequenced by next generation sequencing (RNA-seq). Data analysis was 
performed by Dr. Diego Rodríguez Terrones at the Helmholtz Zentrum München 





Figure 5.31 - Batch effect and batch effect correction 
Total RNA was extracted and purified from mutant mES cell lines and total RNA-seq performed. A PCA 
computed on the non-batch corrected read per million (RPM) matrix. B PCA computed on the batch-
corrected vst-transformed (DESeq2) data. C t-sne computed on the batch-corrected vst-transformed 
(DESeq2) matrix. 
 
Due to experimental reasons, the samples were prepared and sequenced in 
three separate batches. During preliminary quality control analysis, the 
presence of a considerable batch effect became very apparent (figure 5.31A). 
We identified the main cause of this batch effect as being due to high variability 
in genes overlapping ribosomal RNA (rRNA) or major satellites and in small 
non-coding RNAs. Therefore, we removed these RNA classes from the 
analysis. In addition, the batches were corrected with Limma’s 




clustering, as intended, they also led to an apparently loss of clustering among 
replicates on principal component analysis (PCA; figure 5.31B). We 
hypothesized this was normal and simply reflected the complexity of the dataset 
and the multitude of sample classes. In fact, upon computing the batch 
corrected results on t-sne, a non-linear dimensionality reduction method, the 
sample replicates clustered as expected together (figure 5.31C). 
 
5.2.2.1.1 The effects of the different mutant cell lines in gene transcription 
Having corrected for batch effects, we next proceeded to assess how gene 
expression was affected in the mES cells expressing mutated H3.3. We first 
assessed the number of down- and up-regulated genes in each cell line 
compared to the WT control (figure 5.32). Surprisingly, the cell lines carrying 
multiple mimics were not more affected, in terms of number of genes, than the 
cell lines carrying a single unmodified or acetylation mimic. 
 
Figure 5.32 – Summary of differentially expressed genes 
Differential gene expression analysis by DESeq2. Genes with a log2foldChange > +1/ -1 and an adjusted p 





While differentially expressed genes were observed, we were not able to 
identify specific patterns regarding the number of genes affected nor specific 
groups of genes (e.g. GEO terms) that were up-/down-regulated in each un-
modified/acetylated mimic pair, or vice versa (figure 5.33). 
 
Figure 5.33 - Overlap between differentially expressed genes 
Venn diagrams showing overlaps between differently expressed genes, comparing to 2HA.H3.3B, in the 
different mutant pairs: A H3K56R/Q; B H3K64R/Q; C H3K122R/Q; D H3K56K64R/Q and E 
H3K56K64K122R/Q. 
 
5.2.2.1.2 The effects of the different H3.3 mutants on sharp and broad 
promoter genes 
Mammalian gene promoters can be classified into sharp and broad depending 
on the spread of their TSS115. Sharp promoters contain a TATA box and are 
characterized for having a sharp and peaky TSS cluster at a strictly close 




characterized by the absence of DNA methylation. It is estimated that 
approximately 70 % of all promoters correspond to broad promoters, making it 
the most common promoter type in vertebrates117.It has been suggested that 
sharp and broad promoters are associated with different transcriptional 
regulatory elements and, therefore, regulated differently118.  
To define sharp and broad promoters we relied on a published Cap Analysis of 
Gene Expression (CAGE) dataset on mES cells to classify promoters into broad 
and sharp according to their interquartile width. Peaks of 10 or less bases were 
classified as sharp peaks, while peaks above 10 bases were deemed broad 
peaks. We compared the levels of H3.3 on sharp and broad promoters, using an 
available ChIP-seq dataset on mES cells (figure 5.34).  
 
Figure 5.34 - Sharp promoters are enriched with H3.3  
Metagene analysis of mES cells H3.3 ChIP-seq over broad and sharp promoters. 
 
These results revealed that sharp promoters are comparatively enriched for 
H3.3, leading us to hypothesize that genes regulated by sharp and broad 






Figure 5.35 - Acetylation mimics show statistically different fold-change distributions between sharp and 
broad genes 
A Distribution of fold-changes for sharp and broad promoter genes in the indicated mES cell mutants. B 
Mean logarithmic fold-changes for sharp and broad promoter genes in the different mES cell mutants.  
 
We selected for each cell line the differently expressed genes compared to the 
control line, divided them into broad and sharp genes and we compared the 
differently expressed sharp and broad genes within each cell line (figure 5.35). 
For the classification of genes into broad and sharp, we took in consideration 




For the majority of the cell lines, genes regulated by sharp promoters were more 
differently expressed. In particular, acetylation mimics presented a significantly 
higher fold change at sharp genes. Among the single modified mimics, the 
2HA.H3.3K122Q cell line displayed statistically significant differences in fold 
changes in the expression of sharp compared to broad genes. Moreover, the 
two mutants mimicking multiple acetylations also presented statistically 
significant differences between the two types of genes. Interestingly, while in 
2HA.H3.3K122Q and 2HA.H3.3K56K64K122Q sharp genes were, in general, 
downregulated compared to the control cell line, we observed the opposite for 
the cell expressing 2HA.H3.3K56K64Q. In fact, the effect of 
2HA.H3.3K56K64K122Q on sharp promoters is approximately the addition of 
the effects of 2HA.H3.3K122Q and 2HA.H3.3K56K64Q, supporting the idea of 
an additive effect of three H3 core acetylations. 
Together, these results suggest that the effect of lateral surface acetylations 
depends on the type of promoter. Further analysis will be needed to investigate 
the role of functional promoter elements in more detail. 
 
5.2.2.2 Gene induction assays 
Having characterized the general effects of the different mutants on steady-
state RNA expression, next we were interested in understanding how the 
different cell lines affected gene activation in a dynamic system. For that 
purpose, we set up gene induction assays and followed the activation of three 
immediate-early (IE) response genes (c-Fos, Egr-1 and c-Myc), all of which are 
regulated by sharp promoters119–121. 
For these experiments, cells were cultured, prior to induction, for 24 hours in the 




introduction of complete media (containing FBS at a final concentration of 15 %) 
supplemented by 100 nM of 12-O-tetradecanoylphorbol-13-acetate (TPA). TPA 
is a potent tumor promoter that stimulates the protein kinase C signal 
transduction pathway and is extensively used in research as a strong gene 
activator.  
 
5.2.2.2.1 Gene induction assays: system validation 
In order to confirm the enrichment of H3.3 on the promoters of the selected IE 
genes and, consequently, that differences on their expression levels are due to 
the different mutations, we performed crosslinked ChIP assays on the WT 
control. The cells used for this experiment were grown under standard 2i/ LIF 
conditions. One antibody targeting H3.3 and two antibodies targeting the HA tag 
were used. The enrichment of the tagged H3.3 was evaluated by quantitative 
PCR (qPCR) analysis (figure 5.36). The results confirmed that the promoters of 
c-Fos, Egr-1 and c-Myc are indeed enriched for the tagged H3.3. 
 
Figure 5.36 - The promoters of c-Fos, Egr-1 and c-Myc are enriched by H3.3 
Crosslinked ChIP assays were performed on chromatin extracted from the 2HA.H3.3B cell line. Three 
antibodies were used: an anti-H3.3, a polyclonal anti-HA and a monoclonal anti-HA. Enrichment for the 




heterochromatic regions (intergenic region chr5:79296560+79296687 and mariner repeats) were used as 
a negative control. Average and STD of two technical replicates are shown. 
 
Having now shown that, under regular conditions, the promoters of the genes of 
interest are enriched by H3.3, next we wanted to confirm this enrichment was 
maintained during the induction assays. For this purpose, crosslink ChIP assays 
were performed on uninduced (T0), 50 minutes induced (T50) and 210 minutes 
induced (T210) 2HA.H3.3B cells (figure 5.37). The results revealed that not only 
the promoters of c-Fos, Egr-1 and c-Myc continue to be enriched by the tagged 
H3.3, their enrichment increases throughout the induction. 
 
Figure 5.37 - The promoters of c-Fos, Egr-1 and c-Myc are enriched by H3.3 during the induction assays 
Crosslinked ChIP assays were performed on chromatin extracted from the 2HA.H3.3B cell line before (T0) 
and 50 (T50) and 210 minutes (T210) after gene induction. Immunoprecipitation was achieved using a 
polyclonal anti-HA antibody. Enrichment as percentage of input for the tagged H3.3 was assessed by 
qPCR. Average and STD of two technical replicates are shown. 
 
Together these experiments confirm that induction of IE genes can indeed be 








5.2.2.2.2 Gene induction assays on the mES cell lines 
To investigate the effects that the different mimics of acetylated and unmodified 
lysine have during gene activation, we starved the cells from FBS for 24 hours 
and induced gene expression with 100 nM of TPA. Time points were collected 
before the induction (T0) and 20 (T20), 40 (T40), 50 (T50) and 150 minutes 
(T150) after induction. Each IE gene presented its own specific activation 
dynamics: c-Fos and Egr-1 reached maximal mRNA expression around 1 hour 
after induction, while c-Myc showed a relatively slower activation dynamic. 
During preliminary assays (data not shown), we noticed variations in the fold 
changes between experiments. To decrease these effects, we opted to carry out 
simultaneously the experiments on the cell line pair expressing the 
unmodified/acetylated mimic together with the control 2HA.H3.3B cell line. 
These gene expression assays are still on-going. Here we present two sets of 
first results: cell lines expressing the single mimic 2HA.H3.3K56R/Q and the 
triple mimic: 2HA.H3.3K56K64K122R/Q. 
We performed TPA gene induction assays as previously described and 
quantified by qPCR the expression of c-Fos, Egr-1 and c-Myc (figure 5.38). 
Interestingly, for all three genes the 2HA.H3.3K56Q cell line showed the highest 
levels of mRNA, confirming the role of H3K56 acetylation in gene activation. 
Likewise, for c-Fos and Egr-1, the mimic of an un-modified lysine had the lowest 
expression of all the three cell lines, highlighting the importance of H3K56ac 





Figure 5.38 - Gene induction assays on 2HA.H3.3B and 2HA.H3.3K56R/Q pair mES cell lines 
Cell lines were starved from FBS for 24hours before being induced with the re-introduction of FBS and 
supplementation with 100 nM of TPA. The levels of A c-Fos, B Egr-1 and C c-Myc expression were 
quantified by qPCR. The results were normalized to the housekeeping gene Hprt1. Plotted is the relative 
expression normalized to T0. Average of two biological replicates is shown. 
 
We repeated the experiments for the 2HA.H3.3K56K64K122R/Q pair (figure 
5.39). Regarding c-Fos, the triple acetylation mimic expressing cell line showed 
the highest levels of gene activation, presenting an approximately 2-fold 
increase in expression compared to the control cell line and the unmodified 
mimic. In the case of Egr-1, the cell line expressing the acetylation mimic had 
significantly higher mRNA levels, while the unmodified mimic had the lowest. 
These results suggest that the acetylation of lysines 56, 64 and 122 on H3 plays 
a crucial role in the activation of both c-Fos and Egr-1, which was not the case 





Figure 5.39 - Gene induction assays on 2HA.H3.3B and 2HA.H3.3K56K64K122R/Q pair mES cell lines 
Cell lines were starved from FBS for 24hours before being induced with the re-introduction of FBS and 
supplementation with 100 nM of TPA. The levels of A c-Fos, B Egr-1 and C c-Myc were quantified by 
qPCR. The results were normalized to the housekeeping gene Hprt1. Plotted is the relative expression 
normalized to T0. Average of two biological replicates is shown. 
 
Interestingly, the triple acetylation mimic led to a relatively higher increase in the 
transcription of c-Fos (2.3- versus 1.6-fold) and Egr1 (3.2- versus 2.8-fold) 
comparing to H3K56 acetylation mimic.  
Altogether, the in vivo assays demonstrate the importance of these acetylations 
for correct gene expression. The RNA-seq allowed the identification of sharp 
genes as a subset of genes preferentially regulated by these H3 globular 
domain acetylations. Furthermore, the gene induction assays, revealed that 
these acetylations not only affect the steady state levels of gene transcription, 









In the last decades many studies have been published on histone lysine 
acylations, mainly focused on the tails of histones. More recently acetylations in 
the globular domain of histones were described. These works highlight the 
importance of these modifications in chromatin regulation. However, despite the 
advancement of our comprehension on these modifications, several questions 
remain unanswered, including how specific histone PTMs regulate chromatin 
structure or influence its function and how specific combinations of such 
modifications influence one another. 
For the purpose of this thesis, we aimed to investigate the so far poorly 
characterized H3K122succ and to study a possible synergism between three H3 
core acetylations: H3K56ac, H3K64ac and H3K122ac.  
 
6.1 Part 1 – H3K122succ 
Although, the identification of H3K122succ was achieved almost a decade ago, 
only a single study characterizing its function in DNA repair had been 
published66. It remained, however, until now unclear what enzymes are setting 
or removing this PTM and what is its function in transcription. 
 
6.1.1 H3K122succ associates with histone variant H3.3 
H3 histone has several variants in mammals, including the canonical H3, which 
is distributed throughout the genome, and H3.3, a replacement histone variant 
that is for example associated with regulatory regions in euchromatin92. The 
enrichment of specific PTMs varies between histone variants, reflecting their 




H3K9me1122 whereas H3.3 has been shown to be enriched by H3K9ac and 
H3K4me3123.  
In order to have a first hint into the role of H3K122succ, we compared the levels 
of H3K122succ on H3.1 and H3.3. For this we relied on HEK293 cells 
ectopically expressing H3.1 or H3.3 carrying a HA/FLAG-tag. In both cell lines, 
the ectopic gene is under the control of the elongation factor 1 alpha promoter, 
resulting in the stable expression of the tagged H3 throughout the cell cycle. 
This continuous pattern of expression, mimics the normal H3.3 transcription 
pattern, but not the one of H3.1, which peaks during S-phase. Despite using a 
model that does not fully recreate the endogenous expression patterns of the 
two histone variants, our results, nevertheless strongly suggest that 
H3K122succ is enriched on H3.3 relative to H3.1, predicting that H3K122succ 
could be associated with active regulatory elements. 
 
6.1.2 H3K122succ is enriched on active promoters in human MCF7 cells 
Next, we mapped the distribution of H3K122succ throughout the genome in the 
human MCF7 cell line. The results revealed that approximately 50 % of the 
H3K122succ peaks locate near the TSS. These peaks presented a very 
particular distribution pattern, with a single H3K122succ peak centered on the 
TSS. As succinylation reverses the positive charge of the lysine side chain to a 
negative charge, it could disturb the interactions of histones with the DNA and 
therefore lead to the opening up of chromatin. The enrichment of H3K122succ is 
consistent with our previous results showing H3K122succ is enriched on the 
H3.3 variant. To further explore the idea of H3K122succ being associated with 




seq datasets. As expected, H3K122succ peaks shared a considerable overlap 
with open chromatin regions. 
Next, to explore the association between H3K122succ and gene regulation we 
performed metagene analysis, which indicated H3K122succ is enriched at the 
TSS of active genes and tends to gradually decrease downstream of the TSS. 
H3K122succ accumulates at the highest quartile of expressed genes, 
suggesting that highly expressed genes require the establishment and 
maintenance of this mark to properly maintain an open chromatin environment 
and allow transcription.   
Gene transcription is a highly complex process, which depends on the 
coordination of various factors, including histone PTMs90. A wide array of PTMs 
are established in a controlled and articulated manner allowing the orchestration 
of transcription124,125. Functional chromatin regions can be identified by their 
enrichment for histone PTMs. We found that H3K122succ enrichment co-
localizes with H3K4me3, a reference mark for active promoters, in all annotated 
TSS.  
Together, these results identify H3K122succ as an “active chromatin mark”, 
enriched at the TSS of active genes. They also lead us to speculate that the 
presence of H3K122succ could be associated with a role in enhancing DNA 
accessibility and nucleosome depletion, necessary for transcription. 
 
6.1.3 p300/CBP act as H3K122 succinyltransferases 
To identify the succinyltransferases responsible for the establishment of 
H3K122succ we used several approaches, including in vivo depletion of specific 
known HATs and in vitro assays. Consistently, our results identified p300/CBP 




p300 and CBP are two closely related HAT domain containing co-activators. 
They share a high structural homology126 and can acetylate many common 
targets127. Due to their limited substrate selectivity, they can establish several 
histone acetylations, the majority of them located on H3 and H4126. Recently, 
p300 has been shown to establish other acylations, including lysine 
succinylation, propionylation and butyrylation128,129. However, while p300 acts 
as a robust acetyltransferase, it presents weaker activity on longer acyl-CoA 
side chains129 suggesting a preference for ac-CoA.  
The establishment of H3K122succ by p300 supports the notion of H3K122succ 
acting as an active mark. H3K122succ becomes the second modification, after 
H3K122ac, to be identified on lysine 122 of histone H3 that is established by 
p300/CBP. Both the acetylation and succinylation of H3K122 act as active 
marks of transcription and are enriched on active promoters89. These results 
tempt us to speculate that the establishment of one mark over the other on 
active promoter regions could be dependent on the availability of their 
respective acyl-donor groups, e.g. in specific separated chromatin domains. 
 
6.1.4 SIRT5 and SIRT7 can desuccinylate H3K122succ 
Until now, SIRT7 had been identified as the solely enzyme responsible for the 
removal of H3K122succ66. Our results, however, revealed, through in vitro and 
in vivo assays, that both SIRT5 and SIRT7 act as desuccinylases for 
H3K122succ.  
It was previously reported that SIRT5 failed to remove H3K122succ from 
histones in vitro assays66. We, however, show that SIRT5 can consistently 
remove H3K122succ from peptides in vitro and desuccinylate H3K122succ in 




collect previously, we are confident that the use of a Sirt5-KO cell line provides 
a more reliable method to assess enzymatic specificity in vivo. 
SIRT7 is a nuclear protein, whereas SIRT5 is primarily a mitochondrial protein 
that can also be found in the cytosol and in the nucleus130. Both enzymes have 
been shown to act as desuccinylases in vitro131. SIRT5 has been previously 
shown to desuccinylate in vitro H2BK34succ38, however to the best of our 
knowledge this is the first time that SIRT5 has been shown to act as a histone 
desuccinylase in vivo.  
The existence of two enzymes capable of removing H3K122succ could suggest 
a redundancy of activity between SIRT5 and SIRT7. It is, however, feasibly to 
hypothesize that the removal of H3K122succ by one sirtuin over the other is 
associated with specific regulatory functions. Additional experiments would be 
necessary to address this hypothesis. 
 
6.1.5 The role of H3K122succ in transcription 
The involvement of H3K122succ in transcription regulation has been suggested 
by multiple indirect evidence. To directly assess its effect on transcription, we 
set up in vitro transcription assays (see figure 5.12).  
 
6.1.5.1 Suc-CoA stimulates transcription in vitro 
Gene transcription is largely associated with lysine acetylation90. While histones 
are the best described chromatin acetylation substrates, lysine acetylation is not 
restricted to them. In fact, a large variety of non-histones chromatin proteins 
have been shown to be acetylated by HAT enzymes, including the general 




assays on chromatinized templates often include the addition of a recombinant 
HAT enzyme (in our case p300) together with ac-CoA. 
Our results revealed that suc-CoA can stimulate transcription in vitro by 2-2.5-
fold comparing to the no acyl-donor condition, an effect comparable to the one 
of ac-CoA. While these results cannot distinguish the role of histone 
succinylation from non-histone protein succinylation, they highlight the 
importance of this modification in transcription.  
We had previously shown that lysine propionylation plays a role transcription 
activation and in a similar assay confirmed the role of this PTM in gene 
transcription45. Taken together, these two studies emphasize the importance of 
different acylations, besides acetylation, in biological processes such as 
transcription.  
 
6.1.5.2 H3K122succ leads to increased transcription in vitro 
In vitro transcription has been previously used to study histone lysine 
acetylation. Most studies relied on histone tail deletions to assess the influence 
acetylation of these residues have on transcription127,134. Multiple studies 
showed that H3/H4 tail acetylations are required for full p300-dependent 
transcriptional activation, highlighting the importance of H3/H4 tail 
acetylations127,134. More recently, a former student in our lab, Philipp 
Tropberger, used an amber suppression system to generate site-specifically 
acetylated chromatin. Interestingly, the acetylation of H3K18, a H3 tail 
modification enriched at active TSS, did not affect transcription in vitro. 
Whereas, the acetylation of H3K122 stimulated transcription in vitro by 1.6-fold 




Interestingly, both the acetylation and succinylation of H3K122 stimulate 
transcription in vitro to similar extents. H3K122 plays an important role in 
nucleosome stability, as this residue is in water-mediated contact with the 
nucleosomal DNA6. Acetylation of H3K122, has been shown to disrupt this 
contact and ultimately result on histone eviction from the nucleosome36. It is 
largely believed this is the main mechanism behind the role of H3K122ac in 
transcription. Since succinylation reversed the charge of the lysine’s side chain, 
we hypothesized that, likewise, H3K122succ contributed to the destabilization of 
the nucleosome.  
 
6.1.6 H3K122succ affects nucleosome stability in vitro 
To assess the effects of H3K122succ on nucleosome stability we performed 
smFRET assays on WT and H3K122succ mono-nucleosomes. Our results 
revealed that the succinylation of H3K122 destabilizes nucleosomes, resulting 
in higher sensitivity to salt. Due to the position of H3K122, we speculate that the 
destabilization registered in these assays is due to the perturbation of the 
contact between the histone octamer and the DNA, resulting in chromatin 
opening and increased DNA accessibility to transcription factors.  
H3K122succ becomes, therefore, the latest acylation in the globular domain of 
histones to be shown to directly modulate chromatin structure. Adding to the 
previously mentioned H3K122ac, H3K56ac and H3K64ac were shown to 
increase DNA breathing from the nucleosome and destabilize the nucleosome 
structure, respectively, by compromising the octamer-DNA interaction at the 
entry and exit sites of the nucleosomal DNA42,91. More recently, the 
succinylation of H2BK34 and the glutarylation of H4K91 have also been shown 




the importance of histone globular domain acylations in chromatin regulation via 
direct effects on nucleosome stability. 
 
6.1.7 H3K122succ: Working model 
Here we propose a model through which the succinylation of H3K122 
contributes to the regulation of gene transcription (figure 6.1). 
 
Figure 6.1 - Working model for H3K122succ 
The establishment of H3K122succ by p300/CBP might favor an open chromatin state through nucleosome 
destabilization. Higher DNA accessibility facilitates the binding of transcriptional factors and, consequently, 
transcription. The desuccinylation of H3K122succ, by SIRT5 or SIRT7, results in nucleosome stabilization 
and chromatin compaction. 
 
In our model, the establishment of H3K122succ by p300/CBP results in the 
destabilization of the nucleosome and possible displacement of the histone 
octamer from the DNA. Consequently, the DNA fiber is more accessible to 
protein binding. This process is particularly important at TSS, as it facilitates the 
binding of transcriptional factors resulting in transcriptional activation and 
maintenance of active transcription. Reversely, the desuccinylation of 
H3K122succ by SIRT5 or SIRT7 leads to increased chromatin stabilization and 







6.2 Part 2 – The role of histone globular domain acetylations in transcription 
As our comprehension on individual histone PTMs has expanded, the existence 
of a crosstalk between histone modifications has become evident. One of the 
earliest identified examples regards H3S10phos and H3K14ac, where the 
phosphorylation of H3S10 stimulates the acetylation of H3K14 by GCN5136. 
Since then, several other examples of crosstalk between different epigenetic 
elements have been identified137,138. We were interested in extending this 
concept and investigate a possible crosstalk between histone globular domain 
modifications. For this purpose, we selected three H3 core acetylations 
(H3K56ac, H3K64ac and H3K122ac) which have been shown through different 
studies to share both regulatory and functional similarities.  
 
6.2.1 H3 core globular domain acetylations stimulate transcription in vitro 
The acetylations of H3K56, H3K64 and H3K122 have been individually 
correlated with active transcription in separate studies36,37,78. To characterize, 
under similar conditions, how the individual acetylations and combinations of 
these modifications affect transcription, we carried out in vitro transcription 
assays on differently modified chromatin.  
 
6.2.1.1 All three globular domain acetylation stimulate transcription in vitro 
In vitro, all three H3 globular domain acetylations led to the stimulation of 
transcription. Out of the single acetylated chromatin arrays, H3K122ac led to the 
strongest increase in transcription, followed by H3K64ac. H3K122ac is the only 
H3 globular domain acetylation to have been previously tested on in vitro 
transcription assays. While our results recapitulate what has been previously 




(approximately 2.8-fold in our assays versus the previously shown 1.6-fold89). 
We believe, supported by the evidence compiled during the validation of the in 
vitro assays, that the higher extent of the stimulation is due to differences in the 
assays, such as p300 concentration.  
While different approaches have been used to characterize the direct effects 
that the acetylations of lysines 56, 64 and 122 on H3 have on the nucleosome 
stability, general conclusions can be taken from their comparison. H3K56ac has 
been shown to allow DNA-breathing from the histone octamers, increasing, 
therefore, DNA accessibility while maintaining the integrity of the nucleosome42. 
This is a milder effect than the one described for H3K64ac and H3K122ac, 
which have been shown to increase nucleosome instability and histone eviction 
respectively. In fact, in our assays, H3K56ac had the lowest effect on 
transcription. Regarding H3K64ac and H3K122ac, the use of different 
techniques does not allow the quantitative comparison of the effects these 
modifications have on the nucleosome. However, the in vitro transcription 
assays suggest that the destabilization of the histone octamer-DNA interactions 
at the dyad axis could have a stronger effect on nucleosome stability and, 
consequently, on transcription. 
 
6.2.1.2 Combinations of H3 globular domain acetylations lead to higher 
stimulation of transcription in vitro 
To explore a possible synergism in transcription between different H3 globular 
domain acetylations, we compared the effects of different combinations of two 
acetylations. Our results reveal that the two combinations including H3K122ac 
stimulate transcription the most, with both H3K56acK122ac and 




results are consistent with the results we previously obtained, as H3K122ac-
carrying chromatin led to the highest transcription increase among the individual 
acetylations tested.  
A possible mechanism behind these results could lie on the position of these 
residues. While H3K56 and H3K64 are located near the entry and exit sites of 
the nucleosomal DNA, H3K122 is positioned near the dyad axis. Therefore, 
while H3K56acK64ac-carrying nucleosomes are, like their single acetylated 
counter parts, only destabilized at one nucleosomal region, nucleosomes 
containing H3K122ac, as well as, either H3K56ac and H3K64ac are 
destabilized at two important regions of the nucleosome.  
Surprisingly, the triple acetylation of H3 at lysines 56, 64 and 122 did not lead to 
higher stimulation of transcription compared to the double acetylated chromatin. 
Additional experimental replicates would be needed to confirm these results, 
and if confirmed, mechanistic assays would be necessary to fully understand 
them, e.g by using different nucleosome positioning sequences. 
 
6.2.2 The role of H3 core globular domain acetylations in vivo 
To characterize the effects of H3K56acK64acK122ac in vivo, we generated 
mES cell lines with a single endogenous allele encoding for H3.3, which carried 
different mutations mimicking distinct unmodified and acetylated states. This 
model complemented the in vitro transcription assays as it provided a cellular 
model, allowing the characterization of these PTMs.  
We created cell lines carrying either one or all three acetylation mimics, as well 
as their respective unmodified mimic. Additionally, a single combination of two 




These two modifications were chosen as they are the only two residues known 
to be acetylated on H3 near the entry and exit site of the nucleosomal DNA.  
 
6.2.2.1 H3 core globular domain acetylations regulate sharp-promoter genes in 
vivo 
We performed total RNA-seq on the different mutant cell lines. While we did not 
affect global differences in gene expression patterns between the 2HA.H3.3 cell 
line and the cell lines expressing histone mutants, small, yet significant, 
changes were observed when we compared genes with broad and sharp TSS.   
Mammalian Pol II-dependent promoters can be classified into two groups: sharp 
and broad promoters. Sharp promoters contain a TATA-box and are 
characterized for having a sharp and peaky TSS cluster at a strictly close 
distance to the TATA-box116. Broad promoters are GC-rich and frequently 
characterized by the absence of DNA methylation. It is estimated that 
approximately 70 % of all promoters correspond to broad promoters, making it 
the most common promoter type in vertebrates117. In general, sharp promoters 
are associated with tissue specific genes and broad promoters with constitutive 
expressed genes such as housekeeping genes116. Since the two types of 
promoters are associated with different types of regulation, we hypothesized 
that genes controlled by the two promoter types would be differently affected by 
the histone mimics.  
Overall, the acetylation mimics presented a higher differential expression when 
comparing the fold changes of broad- and sharp-promoter genes. Interestingly, 
H3K122Q was the only cell line mimicking a single lysine acetylation that led to 




mimics H3K122ac, the single acetylation that led to the highest increase in 
transcription on the in vitro transcription assays. 
The H3K56K64Q expressing cell line also displayed significant fold change 
differences between broad and sharp genes, however, contrary to 
2HA.H3K122Q where sharp genes were significantly downregulated, in 
2HA.H3K56K64Q sharp genes were up-regulated.  
The triple acetylation mimic also presented significant differences in the 
expression of genes with sharp and broad TSS. These results, again confirm 
the in vitro transcription assays. 
 Altogether, the RNA-seq results demonstrate that lateral surface acetylation 
can affect steady state transcription in cells also with relatively mild effects.  
Taking in consideration these results, we decided to reconsider the viral 
promoter used in the in vitro transcription assays: the adenovirus major late 
promoter. This promoter contains a TATA-box139, resembling a sharp promoter. 
It is tempting to suggest that the similarities between the in vitro transcription 
assays and the in vivo effects of the acetylation mimics on sharp promoter 
genes is, at least partially, due to regulatory similarities between the promoters 
and their regulation by histone globular domain acetylations. 
 
6.2.2.2 H3 globular domain acetylations stimulate gene activation upon TPA 
induction 
Since the effects of laterals surface acetylations on steady state transcription 
are relatively mild, we hypothesized that they might have a stronger effect in a 
dynamic gene expression system. We thus set up gene induction assays, in 
which we silenced and later induced the expression of genes using TPA. We 




regulated by sharp promoters. Although, these experiments are still ongoing 
and we cannot make conclusions regarding the extent of the effects on the 
different mutant, preliminary results confirm the importance of H3K56ac, 
H3K64ac and H3K122ac in gene activation. On the cell lines tested, the 
acetylation mimics were generally associated with higher mRNA expression 
levels upon induction, while the unmodified mimics were correlated with lower 
inductions. These results also suggest that the effects of the PTMs are not 
uniform throughout all genes, as some genes seem to be more affected than 
others by the mimics, i.e.  Egr-1 activation was highly affected by the 
2HA.H3.3K56K64K122Q, which was not the case for c-Myc. 
 
6.2.3 Model for the role of H3 globular domain acetylations in transcription 
Histone acetylation is widely associated with open chromatin and transcriptional 
activation. In this study we explored the potential synergism between H3K56ac, 
H3K64ac and H3K122ac, which allowed us to propose, for the first time, a 
model for crosstalk between H3 globular domain modifications. 
Individually the acetylations of H3K56, H3K64 and H3K122 are associated with 
open chromatin and are enriched at regulatory regions of active genes37,89. We 
propose a model in which these modifications are established at sharp 
promoters, increasing the accessibility of the TSS. The establishment of one or 
more of these acetylations will determine the overall destabilization of the 
nucleosome and, consequently, regulate the transcription level. Maximal 
transcription through maximal DNA accessibility could be obtained when the 
stability of the nucleosome is disrupted on different regions, such as the entry 
and exit sites of the nucleosomal DNA and the dyad axis (figure 6.2). Regarding 




hypothesize it is due to the interference caused by these acetylations on 
chromatin assembly in vitro.  
 
Figure 6.2 - Working model of the synergistic effects between H3 globular domain acetylations 
The establishment of one acetylation at the globular domain of H3 of nucleosomes associated to sharp 
promoters leads to their destabilization, allowing transcription (top panel). The co-existence of more than 















In the context of this thesis I carried out two projects, each tackling specific open 
questions. According to our results, we propose two models for the role of 
lateral surface acetylations and succinylation in transcription. In the first one, we 
suggest that H3K122succ plays a crucial role in the regulation of gene 
transcription, adding, therefore, a new modification to the repertoire of factors 
already known to regulate this process. In the future, it will be interesting to 
explore the function of H3K122succ when enriched in other regions. Our ChIP-
seq data found that approximately 50 % of H3K122succ peaks are located near 
active TSS, it remains unanswered what are the functions of H3K122succ when 
it is not located at these regions (e.g. at enhancers). In the second project, we 
explored the synergism between three H3 globular domain acetylations and 
suggest an interplay between them in the regulation of gene transcription. Our 
future goal is to continue exploring the crosstalk between H3K56ac, H3K64ac 


















Table 7.1 - Peptides 
 
7.2 Primers for ChIP-qPCR 
Table 7.2 - Primers for ChIP-qPCR 
Internal 
number 
Name 5’-3’ sequence 
OL1548 mc-Fos F CCAGATTGCTGGACAATGACCC 
OL1549 mc-Fos R GGAAAGGCAGAGAAGGCGAGC 
OL1556 mEgr-1 F ATGGGAGGGCTTCACGTCACTCC 
OL1557 mEgr-1 R AGTTCTGCGCGCTGGGATCTCTC 
OL1560 mc-Myc F CAGCCTTAGAGAGACGCCTG 
OL1561 mc-Myc R TGTGTTCTTGCCCTGCGTAT 
OL439 mIntergenic F GCTCCGGGTCCTATTCTTGT 
Peptide abbreviation Company Peptide sequence 
H3K9ac Genecust TKQTAR-Kac-STGGKAGC 
H3K18ac IGBMC GGKAPR-Kac-QLATKAGC 
H3K27ac IGBMC ATKAAR-Kac-SAPATGC 
H3K56ac Biosynthan IRRYQ-Kac-STELLIGGC 
H3K64ac Biosynthan STELLIR-Kac-LPFQRLVGC 
H3K115ac IGBMC CAIHA-Kac-RVTIMPK 
H3K122un IGBMC CGGTIMP-K-DIQLA 
H3K122succ IGBMC CGGVTIMP-Ksuc-DIQLA 
H3K122ac IGBMC CGGTIMP-KAc-DIQLA 
H3K122glut IGBMC CGGVTIMP-Kglut-DIQLAR-sre 




OL440 mIntergenic R TCTTGGTTTCCAGGAGATGC 
OL605 mMariner repeats F AGGCAGCAGAGCACAAATG 
OL606 mMariner repeats R TTGCTGTTAAGGGAATTGTGG 
 
7.3 Primers for RT-qPCR 
Table 7.3 - Primers for RT-qPCR 
Internal 
number 
Name 5’-3’ sequence 
OL157  mHprt1 F  GCTGGTGAAAAGGACCTCT 
OL158 mHprt1 R ACAGGACTAGAACACCTGC 
OL1578 mc-Fos F AGGGGCAAAGTAGAGCAGCTA 
OL1579 mc-Fos R CAGTCTGCTTTGTACGAGCCATGGTA 
OL1588 mEgr-1 F TATGAGCACCTGACCACAGAG 
OL1589 mEgr-1 R GCTGGGATAACTCGTCTCCA 
OL1592 mc-Myc F GCTCTCCATCCTATGTTGCGG 
OL1593 mc-Myc R TCCAAGTAACTCGGTCATCATC 
 
7.4 Primers for cloning and mutagenesis 
Table 7.4 - Primers for cloning and mutagenesis 
Internal 
number 
Name 5’-3’ sequence 
OL1153 H3K56amber F GCCGCTACCAGTAGTCCACCGAGCT 
OL1154 H3K56amber R AGCTCGGTGGACTACTGGTAGCGGC 
OL1640 H3K64amber F 
TCCACCGAGCTGCTCATCCGCTAGCTG
CCTTTCCAGC 
OL1641 H3K64amber R 
GACCAGGCGCTGGAAAGGCAGCTAGC
GGATGAGCAGC 
OL1142 H3K122amber F CATCATGCCCTAGGACATCCAGC 




OL1888 H3K56amberK64amber F 
CCGCTACCAGTAGTCCACCGAGCTGCT
CATCCGCTAGCTGCCTTTCC 
OL1889 H3K56amberK64amber R 
GGAAAGGCAGCTAGCGGATGAGCAGCT
CGGTGGACTACTGGTAGCGG 
OL2294 L11C F ATAGGATCCATGACCAAGACCCC 
OL2295 L11C R GTGGATCCTACCTTAGTCCTCCA 
OL2292 T7 BamHI CTGGATCCCGCGAAATTAATAC 
OL2293 Terminator BamHI CTGGATCCCAAAAAACCCCTCA 
OL2296 tRNA optimization_A F CTAGATCTGGAAACGTGATCATGTAG 
OL2297 tRNA optimization_A R CGTTACAAGTATTACACAAAG 
OL2298 tRNA optimization_B F ATCCGTTCAGTGGGGTTAGATTCC 
OL2299 tRNA optimization_B R TTAGAGTCCATTCGATCTAC 
OL2300 tRNA optimization_C F 
TTAGATTCCCCACGTTTCCGCCCAACTA
GTATC 
OL2301 tRNA optimization_C R CCCCACTGAACGGATTTA 










OL2304 pET447 F_Gibson AGGAATCCCATATGATGGATAAAAAACC 









PL1527 pG5-MLP Dr. Raphael Margueron 
pET395 pET15b GAL4-VP16 Dr. Raphael Margueron 




pET380 pCDF PylT-1 H3 Dr. Jason Chin 
pET448 pAcKRS-3 with Trc promoter + L11C Self-made 
pET392 pCDF PylT-1 H3K56amber Self-made 
pET420 pCDF PylT-1 H3K64amber Self-made 
pET382 pCDF PylT-1 H3K122amber Self-made 
pET444 pCDF PylT-1 H3K56amberK64amber Self-made 
pET445 pCDF PylT-1 H3K56amberK122amber Self-made 





PL1644 pFastBac1 Acf1-FLAG Dr Peter Becker 
PL1645 pFastBac1 ISWI-FLAG Dr Peter Becker 
 
7.6 Antibodies 
Table 7.6 - Antibodies 
Internal 
number 
Antigen Species Company 
Catalogue 
number 
 369 H3K122succ Rabbit PTM Biolabs PTM-413 
 H3K122succ Rabbit In house  
 H3K122succ Rabbit In house  
 H3K122succ Rabbit In house  
365 H3K56ac Rabbit Active Motif 39281 
241 H3K64ac Rabbit Active Motif 39545 
369 H3K122ac Rabbit In house PTM-413 
31 H3.3 Rabbit Abcam Ab4263 
110 HA-tag Mouse Roche 11583816001 







Table 7.7 - Chemicals 
Name Source or Specification 
2-[4-(2-hydroxyethyl)piperazin-1-
yl]ethanesulfonic acid (HEPES) 
Roth, Karlsruhe, Germany 
4-(2-Aminoethyl)benzolsulfonylfluorid 
 (AEBSF) 
Sigma-Aldrich, St. Louis, USA 
Acetic acid VWR, Ismaning, Germany 
Acrylamide 40 % 
SERVA Electrophoresis, Heidelberg, 
Germany 
Agarose Roth, Karlsruhe, Germany 
Ammonium sulfate VWR, Ismaning, Germany 
Ammonium chloride Roth, Karlsruhe, Germany 
Ammonium persulfate (APS) Roth, Karlsruhe, Germany 
Ampicillin (1000x stock at 50 mg/mL) Roth, Karlsruhe, Germany 
Beta-mercaptoethanol  
(ß-mercaptoethanol) 
Roth, Karlsruhe, Germany 
Bradford reagent Roth, Karlsruhe, Germany 
Bromophenol blue Sigma-Aldrich, St. Louis, USA 
Calcium chloride (CaCl2) Merck, Darmstadt, Germany 
Cesium chloride (CsCl) Sigma-Aldrich, St. Louis, USA 
Charcoal activated VWR, Ismaning, Germany 
CHIR 99021 
Axon Biochemicals BV, Groningen, the 
Netherlands 
Colloidal coomassie stock Roth, Karlsruhe, Germany 
cOmplete™ EDTA-free protease inhibitor 
cocktail  
Roche, Basel, Switzerland 
Coomassie brilliant blue Roth, Karlsruhe, Germany 
Cysteine-HCl Roth, Karlsruhe, Germany 
Dextran T70 Sigma-Aldrich, St. Louis, USA 
Di-potassium hydrogen phosphate 
(HK2O4P) 
Roth, Karlsruhe, Germany 
Di-sodium hydrogen phosphate 
(Na2HPO4) 




Dimethyl sulfoxide (DMSO) Roth, Karlsruhe, Germany 
Dithiothreitol (DTT) Applichem, Darmstadt, Germany 
Dynabeads Thermo Fisher Scientific, Waltham, USA 
Ethylenediaminetetraacetic acid (EDTA) Roth, Karlsruhe, Germany 
Ethanol (EtOH) 100 % Roth, Karlsruhe, Germany 
Ethidium bromide (EtBr) Roth, Karlsruhe, Germany 
Formaldehyde 37 % Sigma-Aldrich, St. Louis, USA 
Glycerol Roth, Karlsruhe, Germany 
Hydrochloric acid (HCl) Roth, Karlsruhe, Germany 
NP40 Sigma-Aldrich, St. Louis, USA 
IGEPAL CA-630® Sigma-Aldrich, St. Louis, USA 
Imidazole Roth, Karlsruhe, Germany 
Isopropyl β-d-1-thiogalactopyranoside 
(IPTG) 
Roth, Karlsruhe, Germany 
Isoamylalcohol Roth, Karlsruhe, Germany 
Isopropanol VWR, Ismaning, Germany 
Kanamycin (1000x stock at 30 mg/mL) Roth, Karlsruhe, Germany 
Leukemia inhibitory factor (LIF) IGBMC, Strasbourg, France 
Magnesium chloride (MgCl2) Roth, Karlsruhe, Germany 
Nicotinamide (Nam) Alfa Aesar, Haverhill, USA 
Nε-acetyllysine (KAc) Bachem, Bubendorf, Switzerland 
PD 0325901 
Axon Biochemicals BV, Groningen, the 
Netherlands 
Pfu polymerase Thermo Fisher Scientific, Waltham, USA 
Ponceau Red S Sigma-Aldrich, St. Louis, USA 
Potassium chloride (KCl) Roth, Karlsruhe, Germany 
Potassium di-hydrogen phosphate 
(KH2PO4) 
Roth, Karlsruhe, Germany 




RNasin® Ribonuclease Inhibitors Promega, Madison, USA 
Sodium acetate (CH3COONa) Roth, Karlsruhe, Germany 
Sodium azide (NaN3) Roth, Karlsruhe, Germany 
Sodium bicarbonate (NaHCO3) Roth, Karlsruhe, Germany 
Sodium Butyrate (NaBU) Alfa Aesar, Haverhill, USA 
Sodium chloride (NaCl) Roth, Karlsruhe, Germany 
Sodium dihydrogen phosphate (NaH3PO4) Roth, Karlsruhe, Germany 
Sodium dodecyl sulfate (SDS) Roth, Karlsruhe, Germany 
Sodium hydroxide (NaOH) Roth, Karlsruhe, Germany 
Sodium Thiosulfate (Na2S2O3) Sigma-Aldrich, St. Louis, USA 
Spectinomycin (1000x stock at 50 mg/mL) Roth, Karlsruhe, Germany 
Sucrose Roth, Karlsruhe, Germany 
Tetramethylethylenediamine (TEMED) Roth, Karlsruhe, Germany 
Tricine Roth, Karlsruhe, Germany 
Tris-Base Sigma-Aldrich, St. Louis, USA 
Tris-HCl Sigma-Aldrich, St. Louis, USA 
Trition X-100 Roth, Karlsruhe, Germany 
Tween-20 Sigma-Aldrich, St. Louis, USA 
Urea Sigma-Aldrich, St. Louis, USA 
 
7.8 Buffers  
Table 7.8 - Buffers 
Name Composition 
1x Phosphate-Buffered Saline 
(PBS) 
10 mM Na2HPO4 
2 mM KH2PO4 
2.7 mM KCl 
137 mM NaCl  




1x Reconstitution Buffer 
10 mM Tris-HCl (pH 7.5)  
0.5 mM EDTA 
2 M NaCl 
1x Tris-Acetate-EDTA (TAE) 
40 mM Tris-Acetate 
1 mM EDTA 
1x Tris-Borate-EDTA (TBE) 
89 mM Tris-HCl 
89 mM Boric acid  
2 mM EDTA (pH 8.0) 
1x Tris-Buffered Saline Tween 
(TBST) 
150 mM NaCl 
50 mM Tris-HCl pH 8  
0,2 % Tween-20 
1x Tris-EDTA (TE)  
10 mM Tris-HCl (pH 8.0) 
1 mM EDTA (pH 8.0) 
4x Laemmli sample loading 
buffer 
250 mM Tris-HCl (pH 6.8)  
20 % ß-mercaptoethanol 
2 % SDS 
0.1 % Bromphenol blue 
40 % Glycerol 
5X HAT buffer 
25 % Glycerol 
250 mM Tris-HCl (pH 8.0) 
0.5 mM EDTA (pH 8.0) 
740 mM NaCl 
5 mM DTT 
8x Phosphate buffer  
(GAL4-VP16 purification) 
160 mM Sodium Phosphate 
4 M NaCl 
10x Glycine transfer buffer 
247 mM Tris-HCl 
1.9 M Glycine  
10x SDS running buffer 
247 mM Tris-HCl 
1.9 M Glycine  
0.5 % SDS 
BC100  
20 mM Tris-HCl (pH 7.9)  
100 mM KCl 
0.2 mM EDTA 
20 % Glycerol 
Buffer I (Native ChIP) 
300 mM Sucrose 
60 mM KCl 
15 mM NaCl  
5 mM MgCl2 
0.1 mM EDTA (pH 8.0) 
15 mM Tris-HCl (pH 7.5) 
0.5 mM DTT 
0.1 mM AEBSF 
1x cOmplete™ EDTA-free protease inhibitor cocktail 
(5 mM NaBU) 
(5 mM Nam) 
Buffer II (Native ChIP) 
300 mMSucrose  
60 mM KCl 
15 mM NaCl  




0.1 mM EDTA (pH 8.0) 
15 mM Tris-HCl (pH 7.5)  
0.5 mM DTT 
0.1 mM AEBSF 
0.4 % NP40 
1x cOmplete™ EDTA-free protease inhibitor cocktail 
(5 mM NaBU) 
(5 mM Nam) 
Buffer III (Native ChIP) 
1.2 M Sucrose  
60 mM KCl 
15 mM NaCl  
5 mM MgCl2 
0.1 mM EDTA (pH 8.0) 
15 mM Tris-HCl (pH 7.5) 
0.5 mM DTT 
0.1 mM AEBSF 
1x cOmplete™ EDTA-free protease inhibitor cocktail 
(5 mM NaBU) 
(5 mM Nam) 
Buffer A  
(Nuclear extracts preparation) 
10 mM HEPES (pH 7.9)  
1.5 mM MgCl2 
10 mM KCl 
0.5 mM DTT 
Buffer B  
(p300 purification) 
20 mM Tris-HCl (pH 7.5) 
250 mM NaCl 
0.1 % IGEPAL CA-630 
30 mM Imidazole 
1x cOmplete™ EDTA-free protease inhibitor cocktail 
Buffer C  
(Nuclear extracts preparation) 
20 mM HEPES (pH 7.9) 
25 % (v/v) Glycerol 
0.42 M NaCl 
1.5 mM MgCl2 
0.2 mM EDTA 
Buffer D  
(Nuclear extracts preparation) 
20 mM HEPES (pH 7.9) 
20 % (v/v) Glycerol 
0,1 M KCl 
0.2 mM EDTA 
0.5 mM DTT 
ChIP incubation buffer  
(Native ChIP) 
50 mM NaCl 
50 mM Tris-HCl (pH 7.5) 
0.1 mM AEBSF 
5 mM EDTA 
(5 mM NaBU) 
(5 mM Nam) 
Coomassie brilliant blue 
staining 
2 % Coomassie brilliant blue  
40 % EtOH 
10 % Acetic acid 
DB50 buffer 
5 % glycerol 
50 mM Hepes (pH 7.5)  




1 mM EDTA (pH 8.0) 
DB200 buffer 
5 % Glycerol 
25 mM Hepes (pH 7.5)  
200 mM KCl 
1 mM EDTA (pH 8.0) 
0,1 % NP40 
Dialysis Buffer  
(NAP1 purification) 
25 mM HEPES (pH 7.6) 
1 mM EDTA 
10 % (v/v) Glycerol 
100 mM NaCl 
0.01 % (v/v) NP40 
10 mM ß -glycerophosphate 
1 mM DTT 
0.2 mM PMSF 
Dialysis Buffer  
(Native ChIP) 
0.2 mM EDTA (pH 8.0) 
0.2 mM AEBSF 
1 mM Tris-HCL (pH 7.5) 
(5 mM NaBU) 
(5 mM Nam) 
Dilution Buffer  
(Crosslinked ChIP) 
1 % Triton X-100  
2 mM EDTA (pH 8.0) 
150 mM NaCl 20mM Tris-HCl (pH8.0) 
Elution Buffer  
(NAP1 purification) 
50 mM Sodium phosphate (pH 7.6) 
100 mM NaCl 
480 mM Imidazole 
15 % (v/v) Glycerol 
0.01 % (v/v) NP40 
10 mM ß -glycerophosphate 
0.2 mM PMSF 
0.5 mM benzamidine 
Elution Buffer  
(Native ChIP) 
50 mM Tris-HCl (pH 7.5)  
50 mM NaCl 
0.1 mM PMSF 
5 mM EDTA (pH 8.0) 
1 % SDS 
Elution Buffer  
(p300 purification) 
20 mM Tris-HCl (pH 7.5) 
100 mM NaCl 
0.1 % IGEPAL CA-630 
250 mM Imidazole 
10 % (v/v) Glycerol 
1x cOmplete™ EDTA-free protease inhibitor cocktail 
Elution Buffer  
(Crosslinked ChIP) 
100 mM NaHCO3 
1 % SDS 
Final wash buffer  
(Crosslinked ChIP) 
0.1 % SDS 
0.5 % NP40 
2 mM EDTA 
500 mM NaCl 




GAL4-VP16 storage buffer 
20 mM Tris-HCl (pH 7.9)  
20 % (v/v) Glycerol 
100 mM KCl 
1 mM DTT  
0.2 mM EDTA 
HEPES-EDTA-Glycerol (HEG) 
Buffer 
25 mM HEPES (pH7.6) 
0.1 mM EDTA 
10 % Glycerol 
Histone Wash Buffer 
50 mM Tris-HCl (pH 7.5)  
100 mM NaCl 
1 mM EDTA (pH 8.0) 
5 mM ß-mercaptoethanol  
(1 % Triton X-100) 
Incubation buffer  
(Native ChIP) 
50 mM Tris-HCl (pH 7.5) 
75 mM NaCl 
5 mM EDTA (pH 8.0) 
0.1 % NP40 
IPH 
50 mM Tris (pH 8.0) 
150 mM NaCl 
0.5 % NP40 
5 mM EDTA 
L1 lysis buffer  
(Crosslinked ChIP) 
50 mM Tris-HCl (pH 8.0) 
2 mM EDTA (pH 8.0) 
0.1 % NP40  
10 % Glycerol 
L2 lysis buffer  
(Crosslinked ChIP) 
1 % SDS  
10 mM EDTA   
50 mM Tris-HCl (pH 8.0)   
Lysis buffer  
(ACF purification) 
20 mM Tris-HCl (pH 7.9)  
500 mM NaCl 
4 mM MgCl2 
0.4 mM EDTA 
2 mM DTT 
20 mM ß-glycerophosphate 
20 % (v/vl) Glycerol 
0.4 mM PMSF 
1 mM Benzamidine-HCl 
4 µg/ mL Leupeptin 
2 µg/ mL Aprotinin 
Lysis buffer  
(NAP1 purification) 
50 mM Sodium phosphate (pH 7.6) 
500 mM NaCl 
20 mM Imidazole 
15 % (v/v) Glycerol 
0.01 % (v/v) NP40 
10 mM ß -glycerophosphate 
0.2 mM PMSF 
0.5 mM benzamidine 
MNase digestion buffer  
(Native ChIP) 
320 mM Sucrose  




1 mM CaCl2 
0.1 mM AEBSF 
50 mM Tris-HCl (pH 7.5) 
MNase Stop Buffer 
1 % SDS 
200 mM NaCl 20mM EDTA 
NAP1 buffer 
10 mM HEPES (pH 7.6) 
1 mM KCl 
1.5 mM MgCl2 
0.5 mM EDTA 
10 % (v/v) Glycerol 
0.01 % (v/v) NP40 
10 mM ß-glycerophosphate 
1 mM DTT 
0.2 mM PMSF 
P10x 
200 mM HEPES-KOH (pH 7.9) 
80 mM MgCl2 
Ponceau S staining solution 
0.5 % (w/v) Ponceau S 
1 % Acetic acid 
Reaction buffer (histone 
desuccinylation assay) 
20 mM Tris-HCl (pH 7.5)  
1 mM DTT 
Refolding Buffer 
10 mM Tris-HCl (pH 7.5)  
1 mM EDTA (pH 8.0) 
2 M NaCl 
5 mM ß-mercaptoethanol 
SAU200/600 Buffer 
7 M Urea 
20 mM CH3COONa (pH 5.2)  
200 mM/ 600 mM NaCl 
1 mM EDTA (pH 8.0) 
5 mM ß-mercaptoethanol 
SDS running gel 
6 to 18.7 % Acrylamide 
375 mM Trip-HCl (pH 8.8) 
0.1 % SDS 
SDS stacking gel 
5 % Acrylamide 
125 mM Trip-HCl (pH 6.8) 
0.1 % SDS 
Sucrose gradient buffer 
50 mM HEPES (pH 7.5)  
50 mM KCl 
1 mM EDTA (pH 8.0) 
5-40 % (w/v) Sucrose 
Triton extraction buffer (TEB) 
0.5 % (v/v) Triton X-100 in 1x PBS  
300 mM NaCl  
2 mM AEBSF  
1x cOmplete™ EDTA-free protease inhibitor cocktail 
(5 mM NaBU) 
(5 mM Nam) 
Tubing preparation solution I 
2 % (w/v) NaHCO3 
1 mM EDTA (pH 8.0) 





7 M Guanidium hydrochloride  
20 mM Tris-HCl (pH 7.5) 
10 mM DTT 
Wash buffer  
(NAP1 purification) 
50 mM Sodium phosphate (pH 7.6) 
100 mM NaCl 
20 mM Imidazole 
15 % (v/v) Glycerol 
0.01 % (v/v) NP40 
10 mM ß-glycerophosphate 
0.2 mM PMSF 
0.5 mM benzamidine 
Wash buffer  
(Crosslinked ChIP) 
0.1 % SDS 
0.5 % NP40 
2 mM EDTA 
150 mM NaCl 
20 mM Tris-HCl (pH 8.0) 
Wash buffer F  
(ACF purification) 
20 mM Tris-HCl (pH 7.9)  
150 mM NaCl 
2 mM MgCl2 
0.2 mM EDTA 
1 mM DTT 
10 mM ß-glycerophosphate 
15 % (v/v) glycerol 
0.01 % (v/v) NP40 
0.2 mM PMSF 
0.5 mM Benzamidine-HCl 
2 µg/ mL Leupeptin 
1 µg/ mL Aprotinin 
 
7.9 Bacterial strains 
Table 7.9 - Bacterial strains 
Strains Genotype Origin 
DH5alpha 
F– φ80lacZΔM15 Δ(lacZYA-
argF)U169 recA1 endA1 hsdR17(rK, 
mK+) phoA supE44 λ– thi-
1 gyrA96 relA1 
Lab stock 
z-competent BL-






E.coli B F- ompT hsdS(rB‐mB‐) 
dcm+ Tetr galλ (DE3) endA [argU 
ileY leuW CamR] 
Stratagene 
z-competent Rosetta 
Blue (DE3) pLysS 
(for protein 
expression), 
endA1 hsdR17 (rK12-mK12) 
supE44 thi-1 recA1 gyrA96 relA1 










E. coli MG1655 → MDS42 
fhuACDB endA, deletion of 699 
additional genes, ΔprfA::cat 
prfB::prfBf 
Dr. Lei Wang 
C321.A 
E. coli MG1655  (ybhB-
bioAB)::[lcI857 N(cro-ea59)::tetR-
bla] prfA mutS::zeoR 
Addgene 
 
7.10 Mammalian cell lines 
Table 7.10 - Mammalian cell lines 
Name Source or specification 
MCF7  Dr. Kartiki Desai 
MEFs Dr. Yingming Zhao 
MEFs Sirt5-KO Dr. Yingming Zhao 
Hela S3 
Human cervix carcinoma derived 
(transformed by HPV18) immortalized 
HEK293 H3.1‐HA/FLAG Stably transfected with pFP-N1H3.1 
HEK293 H3.3‐HA/FLAG Stably transfected with pFP‐N1 H3.3 
mES cell line: ESW26 MPI Freiburg 
mES cell line H3.3B 
Cell lines were kindly provided by former 
laboratory members Dr. Nithyha 
Parameswaran Kalaivani and Dr. 
Sylvain Daujat (IGBMC, Strasbourg). 
mES cell line 2HA.H3.3B 
mES cell line 2HA.H3.3K56R 
mES cell line 2HA.H3.3K64R 
mES cell line 2HA.H3.3K122R 
mES cell line 2HA.H3.3K56K64R 
mES cell line 2HA.H3.3K56K64K122R 
mES cell line 2HA.H3.3K56Q 
mES cell line 2HA.H3.3K64Q 




mES cell line 2HA.H3.3K56K64Q 
mES cell line 2HA.H3.3K56K64K122Q 
 
7.11 Baculovirus 
Table 7.11 - Baculovirus 
Protein expressed Origin 
His-p300 Dr. Raphael Margueron140 
























8.1 Molecular biology methods 
8.1.1 Polymerase Chain Reaction 
For the amplification of DNA fragments from DNA templates, polymerase chain 
reactions (PCR) were carried out using sequence-specific oligonucleotide 
primers. Due to Pfu DNA polymerase (Agilent Technologies, USA) proofreading 
ability, it was the polymerase chosen for cloning, while the enhanced Pfu Turbo 
DNA polymerase (Agilent Technologies, USA) was the polymerase chosen for 
mutagenesis. 
The components of a standard PCR reaction mix are indicated in table 8.1. 
Table 8.1 - Standard PCR reaction mix 
DNA template  10-100 ng 
10x Pfu reaction buffer 5 µL 
dNTPs 200 µM 
Forward primer 200 nM 
Reverse primer 200 nM 
Polymerase Pfu 1 U 
H2O 50 µL final volume 
 
Table 8.2 contains the steps of a standard PCR reaction. For mutagenesis the 
first 2-4 cycles of the PCR were carried at a lower annealing temperature 







Table 8.2 - Standard PCR cycling parameters 
Initial denaturation 95 °C 2 minutes 











Annealing 55-60 °C 30 seconds 
Elongation 72 °C 1 minutes/ kb 
Final elongation 72 °C 5 minutes 
End 4 °C hold 
 
8.1.2 Agarose gel electrophoresis 
Samples were mixed with 5x DNA loading dye (Thermo Fisher Scientific, USA). 
Depending on the expected DNA fragment size, 0.8-2 % agarose gels in 1x TAE 
and 1x SYBR Safe DNA gel dye (Thermo Fisher Scientific, USA) were 
prepared. After size separation on gel, the results were analyzed under 254 nm 
UV light.  
When necessary, the DNA fragment of interest was cut out of the gel and 
recovered employing the GenElute™ Gel Extraction Kit (Sigma-Aldrich, USA) 
according to the manufacturer’s instructions. 
 
8.1.3 Restriction endonucleases digestion 
FastDigest restriction endonucleases (Thermo Fisher Scientific, USA) were 
used for restriction enzyme digestion of plasmids or DNA fragments. Plasmid 
DNA was simultaneously dephosphorylated with FastAP Thermosensitive 
Alkaline Phosphatase (Thermo Fisher Scientific, USA) according to 







The digested DNA fragment was ligated into the digested and dephosphorylated 
DNA plasmid by T4 DNA ligase (Thermo Fisher Scientific, USA). In a typical 
reaction, DNA fragment and plasmid were mixed in a molar ratio between 3:1 to 
5:1 and incubated in 1x ligase reaction buffer and 0.1 U of T4 DNA ligase O/N at 
16 °C. 
 
8.1.5 Gibson assembly® cloning 
Gibson Assembly® is a restriction endonuclease digestion-independent cloning 
method, based on the presence of homologous overlapping ends on the DNA 
fragments and plasmid of interest. In short, the co-activity of three enzymes - a 
5’ exonuclease generates long overhangs, a polymerase fills in the gaps of the 
annealed single strand regions, and a DNA ligase seals the nicks of the 
annealed and filled-in gaps – allows the assembly of multiple DNA fragments in 
a short period of time142.   
A typical reaction for the ligation of two fragments is described on table 8.3. 
Table 8.3 - Standard Gybson® assembly mix 
DNA fragment 0.5 pmol 
Linearized plasmid 0.1 pmol 
Gibson Assembly® 2x Master Mix (New 
England Biolabs inc., USA) 
10 µL 
Deionized H20 To 20 µL 
 







8.1.6 Heat shock transformation of E. coli 
Competent E. coli were thawed on ice. E. coli (approximately 50 µL) were mixed 
with either 5 µL of ligation mixture or 20-100 ng of DNA plasmid. For the amber 
suppression system, 100 ng of each plasmid were mixed and added to the 
bacteria. Regarding the E. coli strain selection: DH5alpha were used for cloning 
and plasmid propagation, while BL21, Rosetta blue, Jx33 and C321.A were 
used for protein expression. Bacteria were transformed by quickly applying heat 
shock at 42 °C for 90 seconds followed by 5 minutes on ice. Next, 1 mL of LB 
was added to the transformed E. coli, which were allowed to recover for 1 hour 
at 37 °C before being plated on an LB-agar plate supplemented with the 
appropriate antibiotics. 
 
8.1.7 Purification of plasmid DNA from E. coli 
Individual colonies from transformed E. coli were picked from LB-agar plates to 
inoculate LB media supplemented with the appropriate antibiotics. Plasmid DNA 
was purified with GenElute™ Plasmid Miniprep (Sigma-Aldrich, USA) or 
QIAGEN Plasmid Maxi Kit (Qiagen, Germany) according to manufacturer’s 
instructions. 
 
8.1.8 Cesium chloride gradient centrifugation of plasmid DNA for chromatin 
assembly 
Chromatin assembly with NAP1 and ACF requires a very high level of DNA 
purity. For that purpose, after purifying the pG5-MLP plasmid with the QIAGEN 
Plasmid Maxi Kit (Qiagen, Germany) the plasmid was further purified on a 




centrifuged at high g-forces, allowing the separation of intact plasmid DNA from 
nicked, linearized and genomic DNA and RNA. 
500 µg of plasmid DNA were resuspended in 4.5 mL of TE buffer containing 4.4 
g of CsCl at RT. In order to visualize the DNA, 400 µL of 1 mg/ mL EtBr in TE 
was added to the mix. The mix was transferred with a syringe into a Beckmann 
13x51 mm polyallomer OptiSeal™ tube. All air bubbles were removed before the 
tubes were sealed and checked for leakage. Properly sealed tubes were fixed in 
a NVT90 rotor and centrifuged at 48000 rpm O/N at RT. After centrifugation, the 
tubes were collected and placed on a horizontal stand. The lower band, 
containing the supercoiled DNA, was recovered by puncturing the tube just 
below the band. The solution containing the supercoiled plasmid was 
transferred to a new tube. The EtBr was extracted by multiple washed with 
isopropanol saturated with CsCl. Once all remains of EtBr were removed, the 
plasmid DNA was precipitated with the addition of isopropanol (2x the sample 
volume) and centrifugation at 17000 xg for 20 minutes at 4 °C. The DNA pellet 
was washed with 70 % EtOH before being resuspended in 1x TE. Plasmid was 
aliquoted and stored at -20 °C. 
 
8.1.9 RNA purification and Reverse Transcription from mammalian cells 
Total RNA was extracted and purified from mammalian cells using the Quick-
RNA Miniprep kit (Zymo Research, USA) according to the manufacturer’s 
instructions. RNA concentration was measured on a Multiskan Go 
(ThermoFisher Scientific, USA). For reverse transcription 100 ng of total RNA 
were used per reaction. The RevertAid H Minus First Strand cDNA Synthesis Kit 
(ThermoFisher Scientific, USA) was used to synthesize complementary DNA 




Table 8.4 - Standard reverse transcription reaction mix 
5x Reaction buffer 4 µL 
dNTP mix 2 µL 
Oligo(dT) 18 Primer 1 µL 
RiboLock RNase Inhibitor 1 µL 
RevertAid H Minus Reverse Transcriptase 1 µL 
RNA template 100 ng 
Nuclease-free water Up to 20 µL 
 
The reaction components were mixed and incubated for 60 minutes at 42 °C, 
followed by 5 minutes at 70 °C. 
 
8.1.10 Quantitative PCR 
In order to quantify the concentration of specific DNA fragments, qPCRs were 
carried out. The components of a standard reaction mix are indicated in table 
8.5. 
Table 8.5 - Standard qPCR reaction mix 
ABsolute™ Blue qPCR Mix, SYBR Green, ROX 
(Thermo Fisher Scientific, USA) 
10 µL 
Forward primer 250 nM 
Reverse primer 250 nM 
ChIP purified DNA or cDNA 2 µL 
 







Table 8.6 - Standard qPCR cycling parameters 
 Acquisition 
Initial denaturation 95 °C 15 minutes None 









Annealing 60 °C 30 seconds None 
Elongation 72 °C 30 seconds Single 
Melting curve 
60 °C 3 minutes None 
95 °C 1 second Continuous 
 
8.2 Biochemical methods 
8.2.1 Crosslinked ChIP 
Cells were grown on 15 cm dishes until they reached 70-80 % confluency and 
directly crosslinked with formaldehyde (final concentration of 1 %). After 10 
minutes of incubation at RT, the fixation was quenched with glycine (final 
concentration of 125 mM) for 5minutes on ice. The cells were washed twice with 
ice-cold PBS and collected by scrapping in PBS supplemented with cOmplete™ 
EDTA-free protease inhibitor cocktail and the appropriate HDAC inhibitors. All 
following steps were carried out on ice unless indicated otherwise. Cells were 
transferred to a new tube and centrifuged at 600 xg for 5 minutes at 4 °C. Cell 
pellet was resuspended in 1.2 mL/ 15 cm dish of L1 buffer with cOmplete™ 
EDTA-free protease inhibitor cocktail and the appropriate HDAC inhibitors and 
incubated on ice for 5 minutes. The samples were, then, centrifuged at 800 xg 
for 5 minutes at 4 °C. Pellet was resuspended in 1.2 mL/ 15 cm dish of L2 buffer 
with the appropriate HDAC inhibitors. Next, chromatin was fractionated by 
sonication of a Qsonica (80 % amplitude, 20 seconds ON, 20 seconds OFF, for 




mL tubes and centrifuged at 14000 xg for 10 minutes at 4 °C. The supernatant, 
containing the chromatin, was transferred to a new 1.5 mL tube. Chromatin 
concentration was measured on a Multiskan Go (ThermoFisher Scientific, USA) 
and diluted with dilution buffer supplemented with the appropriate HDAC 
inhibitors to 150 ng/ µL. In order to control the sonication efficiency, 100 µL of 
diluted sample were mixed with 400 µL of L2 buffer and 20 µL of 5 M NaCl and 
incubated at 65 °C O/N. The remaining sample was stored on ice. 
On the following day, the de-crosslinked aliquot was purified by phenol: 
chloroform, resuspended in 50 µL of TE buffer and analyzed by agarose gel 
electrophoresis (section 8.1.2). 
For the pre-blocking of the beads, 500 µL of protein A agarose beads were 
mixed with 500 µL of protein G agarose beads (GE Healthcare, USA) in a 2 mL 
tube. The beads were washed three times with 1 mL of TE and incubated O/N 
at 4 °C with 100 µL of pre-boiled single stranded salmon sperm DNA (10 mg/ 
mL) and 100 µL of BSA (10 mg/ mL). On the following day, the beads were 
washed three times with 1mL of TE and stored as a 50 % slurry on TE. 
After confirming the efficiency of the sonication, the sample was pre-cleared. 
For that purpose, for each immunoprecipitation (IP) 40 µg of chromatin were 
diluted in a total volume for 1 mL of dilution buffer supplemented with the 
appropriate HDAC inhibitors. The samples were incubated for 1 hour at 4 °C on 
a rotation wheel with 20 µL of pre-blocked agarose bead-slurry. After incubation 
the samples were centrifuges for 5 minutes at 1000xg and the pre-cleared 
supernatant transferred to new tubes. Antibodies were added to each IP and 
incubated O/N at 4 °C on a rotation wheel, 
On the next day, 50 µL of pre-blocked bead-slurry were added to each IP and 




two times with 1 mL of washing buffer and one time in 50 % wash buffer: 50 % 
final wash buffer. After the last wash, the samples were resuspended in 150 µL 
of elution buffer and incubated for 10 minutes at RT on a rotation wheel. The 
samples were centrifuged for 1 minute at 4000 rpm. The supernatant was 
collected and this step was repeated one more time. The two supernatants were 
pooled together. To each sample 12 µL of 5 M NaCl and 1.56 µL of RNase A 
(10 mg/ mL) were added and the samples were incubated for 30 minutes at 37 
°C. Next, 1 µL of proteinase K (20 mg/ mL) was added to each sample and 
incubated for 4-5 hours at 65 °C. DNA was purified with QIAquick PCR 
Purification Kit (Qiagen, Germany) according to the manufacturer’s instructions. 
 
8.2.2 Native ChIP 
MCF7 (5x107-5x108 cells) were collected and washed with PBS. Cell pellet was 
resuspended in 4 mL of buffer I and divided into two tubes. Next, 2 mL of buffer 
II were added to each tube. Samples were gently mixed and incubated on ice 
for exactly 10 minutes. The samples were carefully layered on top of 8 mL of 
sucrose cushion and centrifuged in a swing-out rotor at 10000 xg for 20minutes 
at 4 C. The supernatant was carefully removed and the pellets were 
resuspended in 1 mL of MNase digestion buffer. Chromatin was fractionated by 
MNase digestion (at a final concentration of 2 U/ mL) for 8-12 minutes at 37 C. 
The digestion was stopped with the addition of 5 mM EDTA. 
Soluble chromatin fractions were collected by centrifugation of digested 
chromatin at 10000 rpm for 10 minutes. The supernatant (S1) was collected, 
while the pellet was resuspended in the same volume of dialysis buffer and 




centrifuged as before and the supernatant was collected (S2). Both fractions 
underwent quality control on an agarose gel electrophoresis. 
Per IP, 40 µg of digested chromatin (20 µg of S1 + 20 µg of S2) were diluted in 
500 µL of ChIP incubation buffer. The input chromatin was pre-cleared by 
incubation with 5 µL of Dynabeads mix (50 % protein A:50 % protein G) for 1 
hour at 4 C. The samples were then incubated O/N at 4 C with different 
amounts of antibody. To each sample, 20 µL of 50 % protein A:50 % protein G 
Dynabeads were added and incubated on a rotating wheel for 2-4 hours. The 
beads were washed three times with ChIP incubation buffer, before being eluted 
with 2x125 µL of elution buffer. The samples were then digested with RNase A 
for 30-45 minutes at 37 C and then purified using the QIAquick PCR 
Purification Kit (Qiagen, Germany) according to the manufacturer’s instructions. 
 
8.2.3 Antibody purification 
For the generation of anti-H3K122succ antibodies, rabbits were immunized with 
the H3K122succ according to the immunization protocol from BioGenes Gmbh 
(Germany). Specific antibodies were affinity purified from rabbit serum in a two-
step purification protocol using SulfoLink Coupling Resin (Thermo Fisher 
Scientific, USA). In short 1 mL of rabbit serum was mixed with EDTA (final 
concentration of 5 mM) and centrifuged for 20 minutes at 10000 xg at 4 °C. The 
cleared supernatant was mixed with 20 µL of SulfoLink Coupling Resin 
coupled to H3K122succ peptides. The sample was incubated for 1 hour at RT 
on a rotation wheel. After the incubation, the beads were washed three times 
with 10 mL of TBS/ 5 mM EDTA. For elution of the antibodies, the beads were 




wheel. The sample was then centrifuged for 1 minute at 2000 xg and the 
supernatant was quickly transferred to a new tube on ice and neutralized with 
3.5 µL of Tris-HCl (pH 9.5). The pH of the eluted antibodies was checked on a 
pH paper and adjusted to reach an approximate pH 8.0. The elution of the 
beads was repeated a total of two times. The two purified supernatants were 
pooled together and mixed with 20 µL of SulfoLink Coupling Resin coupled to 
H3K122glut peptides. The sample was incubated for 30 minutes at 4 °C on a 
rotation wheel. The beads were removed by centrifugation and the purified 
antibodies were dialyzed O/N at 4 °C against 1 L of PBS. After dialysis, sodium 
azide was added to the antibodies (at a final concentration of 0.05 %). The 
antibodies were stored at 4 °C. 
 
8.2.4 SDS-PAGE electrophoresis 
SDS-PAGE is an analytical method that allows the separation of proteins 
according to their molecular weight (MW). The percentage of acrylamide in the 
running gel varied between 6 and 18.7 % depending on the MW of the protein of 
interest. A stacking gel of 5 % polyacrylamide was overlaid on top of the running 
gel. The protein samples were boiled in 1x laemmli loading buffer for 5minutes 
at 95 °C before being loaded on the gel and electrophoresed in 1x SDS running 
buffer for 1-2 hours at 140-200 V depending on the percentage of the gel. After 
electrophoresis the proteins in the gel were either staining with coomassie 








8.2.5 Western Blot transfer 
In order to detect specific proteins or protein PTMs by immunostaining, after 
SDS-PAGE electrophoresis the proteins were transferred from the SDS gel to a 
membrane. The transfer into membranes renders the antigen epitopes 
accessible for antibody recognition. The proteins were transferred from the gel 
to 0.45 µm pore size nitrocellulose membranes in 1x glycine transfer buffer. The 
exact conditions of the transfer depended on the MW and overall charge of the 
protein of interest. For the transfer of histones, the transfer was carried out for 
20 minutes at 350 mA. 
 
8.2.6 Immunostaining of western blots 
After transfer, the nitrocellulose membranes were stained for 2-3 minutes with 
ponceau S in order to visualize the efficiency of the transfer and compare the 
relative amounts of proteins in the membrane. Nitrocellulose membranes were 
then blocked with 4 % BSA in 1x TBST for 1 hour at RT. After blocking, the 
membranes were incubated O/N at 4 °C in different amounts of antibodies in 1x 
TBST. On the following day, the membranes were washed three times in 1x 
TBST for 5 minutes each time before being incubated with the secondary 
antibody conjugated to horseradish peroxidase (HRP) in 4 % BSA in 1x TBST 
for 1 hour at RT. The membrane was washed twice with 1x TBST and once with 
TBS for 5 minutes each.  After the last was the membrane was incubated with a 
Clarity or Clarity Max enhanced chemiluminescent (ECL) western blotting 







8.2.7 Peptide immunoblotting 
Peptide immunoblotting were carried out to test the specificity of the antibodies 
targeting specific histone PTMs. Serial dilutions of unmodified or differently 
modified chemically-synthesized peptides were spotted directly unto 0.1 µm 
pore size nitrocellulose membranes. Membranes were air-dried for a minimum 
of 30 minutes at RT, before being processed at described in 8.2.6. 
 
8.2.8 Purification of native histones by acid extraction 
Histones are proteins rich in basic amino acids and can, therefore, be purified 
from the majority of other nuclear proteins by acid extraction. Cells were 
harvested and the cell pellet was washed twice with ice-cold PBS. The cell 
pellet was resuspended in triton extraction buffer (TEB; final concentration of 
107 cells/ mL). The cells were lysed for 10 minutes on ice and centrifuged for 10 
minutes at 2000 rpm at 4 °C. The pellet was resuspended in TEB (half the 
volume used before) and centrifuged as previously described. The cell pellet 
was resuspended in 0.2 N of HCl (a quarter of the initial volume of TEB used) 
and incubated O/N at 4 °C on a rotational wheel. On the following day, the 
samples were centrifuged for 10 minutes at 10000 rpm at 4 °C. The supernatant 
containing the extracted histones was transferred to a new tube and aliquoted. 
The aliquots of the histone acidic extracts were stored at -20 °C. 
 
8.2.9 Clipping of histone tails by limited trypsin digestion 
Trypsin is a serine protease active on the carboxyl group of lysine and arginine 
residues. Under limiting digestion conditions, it is possible to selectively remove 
histone tails as they are rich in these two residues and are comparatively more 




incubated with 0-5 µg of trypsin for 20 minutes at 26 °C. The reaction was 
stopped with the addition of laemmli loading buffer (at a final concentration of 
1x). 
 
8.2.10 Histone succinyltransferase assay 
For the succinyltransferase assays on rOctamers, 1 µg of sample was incubated 
with 40 ng of p300 in the presence of suc-CoA O/N at 30 C. The reaction 
products were separated by SDS-PAGE and analyzed by immunoblotting with 
an anti-H3K122succ antibody.  
For the succinyltransferase assays on H3K122 peptides, the samples were 
incubated with p300 (0-160 ng) in the presence of [14C]suc-CoA for 
approximately 16 hours (O/N incubation) at 30 C. The reactions were spotted 
on cellulose chromatography paper P81. Chromatography papers were washed 
three times with 10 % TFA before the incorporated radioactivity was measured 
by liquid scintillation counting.  
 
8.2.11 Histone desuccinylation assay 
For the in vitro desuccinylation assays, 1 µg of H3K122succ peptides were 
incubated with 0.5-1.8 µg of SIRT5 or SIRT7 in reaction buffer supplemented, or 
not, with NAD+. After 3 hours at 37 C, 2 µL of each reaction were spotted on 
0.1 µM-pore nitrocellulose membrane and probed with an anti-H2K122succ 
antibody. 
 
8.2.12 Expression of recombinant unmodified histones 
Canonical WT recombinant histones – H2A, H2B, H3 and H4 – were expressed 




plasmid DNA and streaked out on plates containing ampicillin. A single colony 
was picked to inoculate 50 mL of LB supplemented with ampicillin and cultured 
O/N of at 37 °C. On the following day, 1 L of LB supplemented ampicillin was 
inoculated with 25 mL of O/N culture and grown at 37 °C until OD600 reached 
0.4-0.5. The expression of histones was induced with IPTG (final concentration 
of 0.5 mM) and was continued for 3-3.5 hours at 37 °C. The bacteria were spun 
down at 5 minutes at 4000 xg and resuspended in 25 mL histone wash buffer 
without triton X-100 supplemented with cOmplete™ EDTA-free protease 
inhibitor cocktail. The samples were frozen at -80 °C until they were purified. 
 
8.2.13 Expression of acetylated histones 
For the expression of site-specifically acetylated histones, we optimized a 
previously described amber suppression system as described in section 
5.2.1.142. The final system used in this work consisted of four components in 
two separate plasmids, each containing different antibiotics resistance and 
origins of replication.  
Acetylated H3 histones were expressed in BL21(DE3)pLysS cells. The bacteria 
were transformed with 100 ng of each plasmid and plated on LB-agar plates 
supplemented with the appropriate antibiotics (spectinomycin and kanamycin). 
A single colony was picked to inoculate 50 mL of LB, supplemented with 
spectinomycin and kanamycin, and grown O/N at 37 °C. On the following day, 2 
L of pre-warmed supplemented LB were inoculated with 40 mL of O/N culture 
and grown at 37 °C until OD600 reached 0.7-0.8. Acetyl-lysine and nicotinamide 
were added to the culture (at final concentrations of 10 and 20 mM respectively) 
and the culture was transferred to 20 °C. After 30 minutes, IPTG (at a final 




at 20 °C. The bacteria were spun down for 15 minutes at 4000 xg and 
resuspended in 25 mL histone wash buffer without triton X-100 supplemented 
with cOmplete™ EDTA-free protease inhibitor cocktail and Nam (final 
concentration of 20 mM). The samples were frozen at -80 °C until they were 
further purified. 
 
8.2.14 Purification of recombinant histones 
8.2.14.1 Inclusion body purification 
Inclusion bodies containing WT and acetylated histones were purified following 
the same protocol, for the exception that during the purification of inclusion 
bodies containing acetylated histones all buffers were supplemented with Nam 
(at a final concentration of 20 mM). The frozen cell suspension was quickly thaw 
in a water bath at 37 °C. All further steps were carried out on ice, unless stated 
otherwise.  Cell suspension was sonicated on a Branson sonicator for 1minute, 
0.5 seconds ON and 0.5 seconds OFF, at 50 % amplitude for a total of three 
times. The lysate was centrifuged for 10 minutes at 17000 xg to pellet the 
inclusion bodies, the pellet was resuspended in histone wash buffer with 1 % 
triton X-100 (20 mL/ L of culture) and sonicated one time as previously 
described. These steps were repeated a total of four times: in the first two times 
the pellet was resuspended in histone wash buffer with 1 % triton X-100 and in 
the last two times in histone wash buffer without 1 % triton X-100. After the last 
wash, the inclusion body pellet was either stored at -80 °C or the histones were 







8.2.14.2 Purification of WT histones from inclusion bodies 
The inclusion body pellet was resuspended in unfolding buffer (10-20 mL/ L of 
culture) and unfolded for 1 hour at RT on a rotation wheel. After the incubation, 
the solution was centrifuged for 15 minutes at RT at 17000 xg. The supernatant 
was transferred to a new tube and centrifuged as before. The supernatant was 
dialyzed against three changes of 2 L of freshly prepared SAU200 at 4 °C, with 
the second dialysis step performed O/N and the first and third for 3 hours. After 
the last dialysis step, the precipitated material was removed by centrifugation for 
20 minutes at 4 °C at 17000 xg. The cleared supernatant was loaded on a 6 mL 
Resource S cation exchange column (GE Healthcare, USA) pre-equilibrated 
with SAU200 and separated with a ÄKTA Prime FPLC in a 40 mL linear gradient 
from SAU200 to SAU600 – a gradient of 0 to 100 % was used for the purification 
of H2A, H2B and H3 and a gradient of 30 to 100 % was used for the purification 
of H4. Fractions of 500 µL were collected and the fractions associated with the 
peak were analyzed by SDS-PAGE followed by coomassie staining. The 
fractions containing the purified histone were pooled together and dialyzed 
against three changes of 2 L of distilled water supplemented with ß-
mercaptoethanol (final concentration of 2 mM) at 4 °C, with the second dialysis 
step performed O/N and the first and third for 3 hours. Dialyzed histones were 
centrifuged for 20 minutes at 4 °C at 17000 xg. The concentration of the 
histones in the supernatant was quantified using the OD276 according to the 





𝑚𝑜𝑙𝑎𝑟 𝑒𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 (𝜀)
× 𝑀𝑊 . 
Molecular weight and molar extinction coefficients for each histone are listed in 





Table 8.7 - Molecular weight and molar extinction coefficient of core human histones 
Histone Molecular weight 
ε for cm/ M 
276 nm 
H2A 13960 4050 
H2B 13774 6070 
H3 15273 4040 
H4 11236 5400 
 
8.2.14.3 Purification of acetylated histones from inclusion bodies 
For the purification of acetylated histones from inclusion bodies nicotinamide (at 
a final concentration of 20 mM) was added to all buffers. The inclusion body 
pellet was resuspended in unfolding buffer (10-20 mL/ L of culture) and unfolded 
for 1 hour at RT on a rotation wheel. After the incubation, the solution was 
centrifuged for 15 minutes at RT at 17000 xg. The supernatant was transferred 
to a new tube and centrifuged as before. The cleared supernatant was then 
filtered on a 0.45 µm pore size syringe filter. The sample were then loaded on a 
HiPrep 26/60 Sephacryl S-200 HR gel filtration column (GE Healthcare, USA) 
pre-equilibrate with freshly prepared SAU200. The sample was eluted with 
SAU200 buffer, while 5 mL fractions were being collected. The fractions 
associated with the peak were analyzed by SDS-PAGE followed by coomassie 
staining and the ones containing the purified histone were pooled together and 
loaded on a Resource S cation exchange column (GE Healthcare, USA) pre-
equilibrated with SAU200. From this step onwards, the purification of the 
acetylated histones was carried out as previously described for the WT histones 






8.2.15  Refolding of histone octamers 
For the refolding of histone octamers, the lyophilized core histones were 
resuspended in unfolding buffer, for a final concentration of 1mg/mL and 
incubated for 1 hour at RT on a rotation wheel. After unfolding the concentration 
of each core histone was measured by OD276 as described in table 8.7. Next, 
the molarity of each histone was calculated taking in consideration that 1 mg/ 
mL of solution corresponds to the following concentrations: 
H2A 71.6 nmol/ mL 
H2B 72.6 nmol/ mL 
H3  65.5 nmol/ mL 
H4  89 nmol/ mL 
The four core histones were mixed in equimolarity and dialyzed against three 
changes of 2 L refolding buffer at 4 °C, in which the second dialysis was carried 
out O/N while the first and third were carried out for 3 hours each. After the last 
dialysis, the sample was centrifuged for 15 minutes at 17000 xg to remove any 
precipitated material. The refolded octamers were concentrated to 300-500 µL 
using a VivaSpin 4 ultrafiltration device (Sartorius, Germany), with a 30 kDa 
cutoff, before being loaded on a Superdex200 Increase HR 10/30 column (GE 
Healthcare, USA) connected to a Äkta Prime FPLC system pre-equilibrated with 
refolding buffer. Sample was eluted with refolded buffer and fractions of 400 µL 
were collected and analyzed on an SDS-PAGE gel. Fractions containing 
stochiometric amounts of all four histones were pooled together and 






𝑚𝑜𝑙𝑎𝑟 𝑒𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 (𝜀)




octamers is 108515 and molar extinction coefficient  is 44950. The samples 
were diluted to 1 mg/ mL in 50 % glycerol and stored at -20 °C. 
 
8.2.16  NAP1 purification 
NAP1 was purified from cell pellets of baculovirus-infected Sf9 insect cells 
expressing N-terminally His-tagged NAP1 as previously described143. After 
harvesting the cells by centrifugation, the cell pellet was washed with ice-cold 
PBS. All subsequent steps were performed on ice unless stated otherwise. The 
cell pellet was resuspended in lysis buffer (1/40 of the initial cell culture volume) 
and homogenized by sonication (3 series of 1 minute, with 50 % amplitude, 0.5 
seconds ON and 0.5 seconds OFF). The sample was cleared by centrifugation 
for 10 minutes at 15000 xg at 4 °C and the supernatant was loaded on a pre-
equilibrated 5 mL HisTrap HP column (GE Healthcare, USA) connected to an 
Äkta pure. After loading the sample, the column was washed with lysis buffer 
and with wash buffer. NAP1 was eluted with 42 mL of elution buffer and 
fractions of 500 µL were collected and analyzed on an SDS-PAGE gel. The 
fractions containing NAP1 were pooled together and dialyzed against two 
changes of 4 L of dialysis buffer, where the first dialysis was carried out O/N and 
the second for 2 hours and against one change of 4 L of NAP1 buffer plus 100 
mM NaCl for 2 hours. 
After dialysis, any precipitate was removed by centrifugation for 20 minutes at 
20000 xg. The soluble protein was quantified on an 8% SDS-PAGE gel followed 
by coomassie staining, using BSA as a mass standard. The sample was loaded 
on a pre-equilibrated 6 mL Resource™ Q (GE Healthcare, USA) column 
connected to an Äkta pure. The column was washed with NAP1 buffer plus 200 




supplemented with 200 mM NaCl to NAP1 buffer plus 500 mM NaCl. Fractions 
of 0.5 mL were collected during elution and analyzed on an 18 % SDS-PAGE 
gel. The fractions corresponding to the first peak contained a 14 kDa 
contaminant in addition to the 65 kDa NAP1 band. The 14 kDa contaminant 
corresponds to a NAP1 inhibitor, therefore all fraction containing any traces of 
this contaminant were discarded.  The fraction corresponding to the second 
peak, which are contaminant-free, were pooled together and dialyzed against 
two changes of 2 L of NAP1 buffer plus 100 mM NaCl, for 2 hours each. The 
protein concentration was quantified by SDS-PAGE gel followed by coomassie 
staining, frozen in liquid nitrogen and stored at -80 °C. 
 
8.2.17 ACF purification 
ACF was purified from cell pellets of baculovirus-infected Sf9 insect cells as 
described144. Pellet was resuspended in 8 mL of lysis buffer F and Dounce 
homogenized using an “A” pestle (three series of ten strokes over 30 minutes, 
on ice). Homogenate was centrifuged for 10minutes at 11000 rpm at 4 °C. The 
supernatant was transferred to a new tube and mixed with 250 µL of FLAG-M2 
resin and 7 mL of dilution buffer F. The slurry mix was incubated for 2-4 hours at 
4 °C on a rotation wheel. After incubation the samples was centrifuged for 3 
minutes at 2000 rpm at 4 °C. The supernatant was removed and the pellet 
resuspended in 12 mL of wash buffer F by tube inversion. The wash was 
repeated three additional times. For elution, the pellet was resuspended in 100 
µL of wash buffer F supplemented with FLAG peptide and insulin (final 
concentration of 0.4 mg/ mL each). The sample was incubated for 10 minutes 
on ice and, then, centrifuged for the 30 seconds at maximum speed. The 




and elution was repeated two more times. The supernatants were pooled 
together and aliquoted. Aliquots were frozen in liquid nitrogen and stored at -80 
°C144. 
 
8.2.18 Chromatin assembly by NAP1 and ACF 
The assembly of the recombinant chromatin used for the in vitro transcription 
assays relied on the activity of histone chaperone NAP1 and chromatin 
remodeling complex ACF, which resulted in the assembly of regularly spaced 
chromatin arrays145. 
For a standard reaction, HEG buffer supplemented with 0.2 mM AEBSF, 2 mM 
NaBU, 1 mM DTT and 100 ng/ uL of BSA (the final reaction volume was 140 µL) 
were mixed with 7 µL of 1 M KCl and 8 to 12 µL of diluted histone octamers at 
100 ng/µL. Since the histone octamer:DNA ratio is critical for efficient success of 
the assembly, different ratios were tested to titrate the assembly of each 
chromatin type ranging from 0.8:1 to 1.2:1. The reaction was mixed by gentle 
vortexing and 2 µL of NAP1 (at a concentration of 1.8 µg/ µL in HEG buffer) 
were added. The reaction was gently mixed and incubated for 30 minutes at RT.  
In the meantime, the ATP-regenerating system was prepared by mixing 13.5 µL 
HEG buffer, 90 µL 500 mM of creatine phosphate, 1.5µL of creatine 
phosphokinase (5 µg/ µL), 45 µL of 100 mM ATP and 30 µL 250 mM MgCl2. 
After the incubation, the following components were added: 4 µL of ACF (at a 
concentration of 70 ng/ µL in HEG buffer), 16.8 µL of freshly prepared ATP-
regenerating system and 10 µL of plasmid DNA (at 100 ng/ µL in HEG buffer). 
The reaction was briefly spun down and incubated for 3 hours at 27 °C 





8.2.19 MNase digestion of in vitro assembled chromatin 
To assess the efficiency of the chromatin assemblies, the samples were 
submitted to limited MNase digestion. Two chromatin assembly reactions were 
pooled together of which 200 µL of chromatin (corresponding to approximately 
1.4 µg) were transferred to a new 1.5 mL tube and mixed with CaCl2 (at a final 
concentration of 2 mM). The sample was split into two aliquots and each was 
mixed with 6 to 30 mU MNase/ µL in 5 µL of HEG buffer. The samples were 
quickly mixed and incubated for 10 minutes at 30 °C. The digestions were 
stopped by the addition of 110 µL of MNase stop buffer and were incubated for 
1hour at 37 °C. The DNA was phenol:chloroform extracted and EtOH 
precipitated. The DNA pellet was resuspended in 15 µL of 1x DNA loading dye 
and electrophoresed in a 1.3 % unstained agarose gel. After separation, the gel 
was stained with EtBr (at a final concentration of 10 µg/ mL). 
 
8.2.20 Sucrose gradient centrifugation of in vitro assembled chromatin 
In order to select for similarly assembled chromatin arrays, the recombinant 
chromatin arrays were purified according to their density on sucrose gradients. 
5mL linear sucrose gradients of 10-40 % sucrose in sucrose gradient buffer 
were prepared and overlaid with 400 µL of sample. The gradients were 
centrifuged in a SW55Ti rotor (Beckman, USA) for 3 hours at 48000 rpm at 4 
°C. The run was stopped without any brake and the gradient was fractionated in 
300 µL aliquots. From each fraction, 5 µL aliquots were collected and mixed 
with 1 % SDS and 1x DNA loading dye. The samples were analyzed on an un-
stained 1.3 % agarose gel. After separation, the gel was stained with EtBr (at a 





8.2.21 GAL4-VP16 purification 
His-tagged GAL4-VP16 was expressed in BL21. After expression E. coli were 
harvested by centrifugation for 30 minutes at 1000 xg at 4 °C. All further steps 
were carried out on ice or at 4 °C. The bacterial pellet was washed once with 
ice-cold PBS and resuspended in 5 packed cell volumes (PCV) of ice-cold 1x 
phosphate buffer supplemented with 20 mM of imidazole. The bacteria 
suspension was sonicated on a Branson sonicator for 1 minute, 0.5 seconds ON 
and 0.5 seconds OFF, at 50 % amplitude for a total of three times and 
centrifuged for 10 minutes at 12000 xg. The supernatant was transferred to a 
new tube and filtered on a 0.45 µm pore size syringe filter. The filtered sample 
was loaded on a pre-equilibrated HisTrap HP column (GE Healthcare, USA) 
connected to an Äkta pure. After loading the sample, the column was washed 
with 10 column volumes (CV) of 1x phosphate buffer supplemented with 20 mM 
of imidazole and the purified GAL4-VP16 was then eluted with 5 mL of 1x 
phosphate buffer supplemented with 500 mM of imidazole. Fractions of 500 µL 
were collected and analyzed on an SDS-PAGE gel. The fractions containing the 
purified sample were pooled together and progressively dialyzed, using a 
peristaltic pump, against 2 L 1x PBS over a period of 16 hours. After the first 
dialysis, the sample was progressively dialyzed against 2 L of GAL4-VP16 
storage buffer. Any precipitate was removed by centrifugation and the sample 
was aliquoted and snap frozen on liquid nitrogen before stored at -80 °C. 
 
8.2.22 p300 purification 
His-tagged p300 was expressed on baculovirus-infected Sf9 insect cells. After 
expression the cells were harvested by centrifugation for 5 minutes at 400 xg at 




was resuspended in 2.5 mL of buffer B and Dounce homogenized with 10 
strokes using an “A” pestle. The sample was incubated on ice for 15 minutes 
before being aliquoted into 700-800 µL aliquots and sonicated (3 series of 5 
minutes, with 90 % amplitude, 30 seconds ON and 30 seconds OFF). The 
aliquots were pooled together and centrifuged for 15 minutes at 16000 xg at 4 
°C. The clarified supernatant was loaded on a pre-equilibrated 1 mL HisTrap HP 
column (GE Healthcare, USA) connected to an Äkta prime. After loading, the 
column was washed with buffer B and eluted with 10CV of elution buffer (500 µL 
fraction were collected during the elution). The different fractions were analyzed 
on a 4-12 % SDS-PAGE gel followed by coomassie staining. The fractions 
containing the purified p300 were pooled together and diluted with 50 % glycerol 
before being aliquoted at snap frozen in liquid nitrogen. The aliquots were 
stored at -80 °C. 
 
8.2.23 Nuclear extract preparation for in vitro transcription 
The preparation of the nuclear extracts for the in vitro transcription assays 
followed a protocol from Dignam et al146. Hela S3 spinner cells were grown to a 
density of 5x105 to 1x106 cells/ mL. Cells were harvested by centrifugation for 
10 minutes, at 500 xg at 4 °C. All further steps were carried out on ice or at 4°C. 
The cell pellet was resuspended in ice cold PBS (10 mL per liter of culture), 
transferred to a 50 mL tube and centrifuged for 10 minutes, at 500 xg at 4 °C. 
The cells were washed with PBS a total of two times as previously described. 
The cell pellet was, then, resuspended in 5 PCV of buffer A and incubated on 
ice for 10 minutes. The sample was centrifuged for 10 minutes at 750 xg and 
resuspended in 2 PCV of buffer A. The cell suspension was transferred to a 




efficiency of the lysis was checked under the microscope and, if necessary, the 
Dounce homogenization was repeated until approximately 70 % of all cells were 
lysed. The cell lysate was centrifuged for 20 minutes at 10000 rpm. After 
centrifugation, the cytoplasmic supernatant was decanted and any traces of 
lipids were removed from the top of the tube. The nuclear pellet was centrifuged 
for 20 minutes at 25000 xg in order to remove any traces for residual 
cytoplasmic material. The nuclear pellet was, then, resuspended in buffer C (3 
mL per 1x109 cells) and extracted by gentle stirring with a small magnetic 
stirring bar for 30 minutes on ice. The nuclear extract was separated by 
centrifugation for 20 minutes at 25000 xg and transferred to a new tube. Next, 
the nuclear extract was either dialyzed against 50 volumes of buffer D for 
5hours or concentrated by ammonium sulfate precipitation. For the 
concentration of the nuclear extracts, ammonium sulfate was slowly added to 
the nuclear extract (0.33 g/ mL of buffer C) over 15 minutes and stirred with a 
magnetic stir bar for 30 minutes on ice. The sample was centrifuged for 20 
minutes at 25000 xg and resuspended in buffer D (¼ to ½ of the volume of 
buffer C used for the extraction). The resuspended nuclear extract was dialyzed 
against 50 volumes of buffer D for 5 hours. After dialysis, the nuclear extract 
was centrifuges for 20 minutes at 25000 xg and the clear supernatant was 
aliquoted and snap frozen in liquid nitrogen. The nuclear extract aliquots were 
stored at -80 °C. 
 
8.2.24 In vitro transcription assays 
For in vitro transcription assays, per reaction, 50 ng of purified chromatin in 7 L 
were mixed with 6 L of BC100 buffer, 7.2 L of c-mix (21.45 µL of P10x, 33 µL 




187.5 mM ammonium sulfate) and pre-incubated with 50 ng of recombinant 
GAL4-VP16 for 15 minutes at room temperature. Next, 40 ng of recombinant 
p300, as well as 1 L of a co-enzyme mix (500 nM ac-CoA or suc-CoA and 200 
mM sodium butyrate) were added and incubated for 30 minutes at 30 C. 10 L 
of Hela nuclear extracts were added and the reaction was incubated for 30 
minutes at 30 °C. A 3 μL mix of ribonucleotides (16.5 μL of 12 mM rATP, rGTP 
and rCTP, 5.5 μL rUTP-32P (Perkin BLU007H; Perkin-Elmer, USA), 4.4 μL 
RNasin® and 6.6 μL ddH2O) were added and transcription was allowed for 40 
minutes at 30 °C. The reaction was chased with the addition of a 6 μL rUTP-mix 
(600 μM rUTP and 6 U/ μL RNase T1) and incubated for 20 additional minutes. 
The transcribed RNA was phenol:chloroform extracted, precipitated with ethanol 
and analyzed on 6 % acrylamide denaturing gels147. A phosphor screen was 
used to capture the signal O/N and was then measured on an Amersham 
Typhoon 5 Biomolecular Imager (GE Healthcare, USA). The signal 
quantifications were done by ImageJ (Java). 
 
8.3 Cell culture methods 
8.3.1 Cell culturing 
All cells were maintained at 37 °C in a humidified atmosphere containing 5 % 
CO2. MCF7 and HEK293 were grown in low-glucose DMEM, supplemented with 
10% fetal bovine serum, 2 mM L-glutamine, 100 U/ mL penicillin and 0.1 mg/ mL 
streptomycin. MEFs were cultured in high-glucose DMEM, supplemented with 
15 % FBS, 1x pyruvate, 20 mM HEPES, 2 mM L-glutamine, 100 U/ mL penicillin 
and 0.1 mg/ mL streptomycin. mES cells were cultured in high-glucose DMEM, 




%, non-essential amino acids, 0.1 mM ß-mercaptoethanol, 2x LIF and 2i (final 
concentration of 25 ng/ mL of PD 0325901 and 75 ng/ mL of CHIR 99021) 
 
8.3.2 siRNA transfection of mammalian cells 
Depletion of HAT enzymes was achieved by RNAiMAX (Invitrogen, USA) 
combined with a reverse transfection protocol following the supplier’s 
instructions. The following ON-TARGETplus SMARTpools from Dharmacon 
(Horizon Discovery, UK) were used: p300, L-003486-00-0010; CBP, L-003477- 
00-0010; pCAF, L-005055-00; scramble negative control, D-001810-10. In brief, 
a mixture of 10-50 nM of siRNA and lipofectamine was pre-incubated for 20 
minutes at RT and mixed with MCF7 cells before plating them. Cells were grown 



















9. Abbreviations  





































Bromodomain protein 4 
Cap Analysis of Gene Expression 
Chromatin immunoprecipitation 
ChIP-massively parallel DNA sequencing 
Clustered Regularly Interspaced Short Palindromic 
Column volume 
Deoxyribonucleic acid 




Formaldehyde-assisted isolation of regulatory 
elements sequencing 
Fetal bovine serum 









C-terminal domain of L11 
Lysogeny broth 















































Polymerase chain reaction  
Principal component analysis 





Release factor 1 
Ribonucleic acid 
RNA polymerase II 





Short interfering RNA 
Sirtuin 5 
Sirtuin 7 














































































Rotations per minute 
Reads per million 
Units 
Volts 
Volume per volume 
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